{"items": "110", "sentiment_score_definition": "x <= -0.35: Bearish; -0.35 < x <= -0.15: Somewhat-Bearish; -0.15 < x < 0.15: Neutral; 0.15 <= x < 0.35: Somewhat_Bullish; x >= 0.35: Bullish", "relevance_score_definition": "0 < x <= 1, with a higher score indicating higher relevance.", "feed": [{"title": "Pyxis Oncology's Deprioritizes Second Pipeline Asset, Analyst Applauds Move - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/general/biotech/24/12/42622590/pyxis-oncologys-deprioritizes-second-pipeline-asset-analyst-applauds-move", "time_published": "20241220T161353", "authors": ["Vandana Singh"], "summary": "Pyxis Oncology, Inc. PYXS announced on Thursday, a portfolio prioritization, focusing resources on advancing its lead clinical program, PYX-201. Pyxis Oncology's second clinical program, PYX-106, is being deprioritized to allocate resources toward advancing the lead asset, PYX-201.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/12/20/pharma-lab-worker-ai.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}], "overall_sentiment_score": 0.060341, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.495015", "ticker_sentiment_score": "0.138777", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Portfolio Prioritization, Focusing Resources on its Lead Clinical Program, PYX-201", "url": "https://www.globenewswire.com/news-release/2024/12/19/3000256/0/en/Pyxis-Oncology-Announces-Portfolio-Prioritization-Focusing-Resources-on-its-Lead-Clinical-Program-PYX-201.html", "time_published": "20241219T210800", "authors": ["Pyxis Oncology"], "summary": "- The Company will focus resources on advancing its lead asset, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.072025, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.163354", "ticker_sentiment_score": "0.056172", "ticker_sentiment_label": "Neutral"}]}, {"title": "Nasdaq Edges Higher; Baidu Shares Fall After Q3 Results - Baidu  ( NASDAQ:BIDU ) , Cool Co  ( NYSE:CLCO ) ", "url": "https://www.benzinga.com/24/11/42121847/nasdaq-edges-higher-baidu-shares-fall-after-q3-results", "time_published": "20241121T193933", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining by more than 500 points on Thursday. The Dow traded up 1.24% to 43,945.57 while the NASDAQ rose 0.09% to 18,982.36. The S&P 500 also rose, gaining, 0.62% to 5,953.83.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/21/Baidu-Photo-by-testing-on-Shutterstock.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.972476"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.154826, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "QUBT", "relevance_score": "0.151539", "ticker_sentiment_score": "0.126408", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.151539", "ticker_sentiment_score": "0.132824", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.2256", "ticker_sentiment_score": "0.253305", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BIDU", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.046055", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLCO", "relevance_score": "0.151539", "ticker_sentiment_score": "0.250693", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KURA", "relevance_score": "0.2256", "ticker_sentiment_score": "-0.11034", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNBWF", "relevance_score": "0.076115", "ticker_sentiment_score": "-0.065659", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTI", "relevance_score": "0.151539", "ticker_sentiment_score": "0.459555", "ticker_sentiment_label": "Bullish"}, {"ticker": "KYKOF", "relevance_score": "0.076115", "ticker_sentiment_score": "-0.065659", "ticker_sentiment_label": "Neutral"}]}, {"title": "Crude Oil Gains 1%; Deere Posts Better-Than-Expected Earnings - Deere  ( NYSE:DE ) , Cool Co  ( NYSE:CLCO ) ", "url": "https://www.benzinga.com/24/11/42119233/crude-oil-gains-15-deere-posts-better-than-expected-earnings", "time_published": "20241121T173222", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded mixed midway through trading, with the Dow Jones index gaining by more than 400 points on Thursday. The Dow traded up 1.03% to 43,855.97 while the NASDAQ fell 0.10% to 18,948.11. The S&P 500 also rose, gaining, 0.41% to 5,941.38. In trading on Thursday, communication services ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/21/oil-prices-5079975.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.961735"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.125249, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "QUBT", "relevance_score": "0.156461", "ticker_sentiment_score": "0.128918", "ticker_sentiment_label": "Neutral"}, {"ticker": "DE", "relevance_score": "0.23281", "ticker_sentiment_score": "-0.166239", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PYXS", "relevance_score": "0.156461", "ticker_sentiment_score": "0.135459", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.23281", "ticker_sentiment_score": "0.259479", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLCO", "relevance_score": "0.156461", "ticker_sentiment_score": "0.255499", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KURA", "relevance_score": "0.23281", "ticker_sentiment_score": "-0.113156", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNBWF", "relevance_score": "0.078611", "ticker_sentiment_score": "-0.065881", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTI", "relevance_score": "0.156461", "ticker_sentiment_score": "0.467213", "ticker_sentiment_label": "Bullish"}, {"ticker": "KYKOF", "relevance_score": "0.078611", "ticker_sentiment_score": "-0.065881", "ticker_sentiment_label": "Neutral"}]}, {"title": "Biotech Stock Roundup: SAGE, INCY Suffer Setbacks, JAZZ Wins Oncology Drug Approval & More", "url": "https://www.zacks.com/stock/news/2373588/biotech-stock-roundup-sage-incy-suffer-setbacks-jazz-wins-oncology-drug-approval-more", "time_published": "20241121T171300", "authors": ["Zacks Equity Research"], "summary": "SAGE and INCY suffer setbacks due to the failure of HD and CSU studies, respectively.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/52/873.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.071757, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "INCY", "relevance_score": "0.197816", "ticker_sentiment_score": "-0.059307", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.197816", "ticker_sentiment_score": "0.046181", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAGE", "relevance_score": "0.38366", "ticker_sentiment_score": "-0.058037", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.099683", "ticker_sentiment_score": "0.062317", "ticker_sentiment_label": "Neutral"}]}, {"title": "Dow Jumps Over 100 Points; Nvidia Posts Upbeat Earnings - Kura Oncology  ( NASDAQ:KURA ) , Perspective Therapeutics  ( AMEX:CATX ) ", "url": "https://www.benzinga.com/24/11/42115220/dow-jumps-over-100-points-nvidia-posts-upbeat-earnings", "time_published": "20241121T151941", "authors": ["Avi Kapoor"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones index gaining by more than 100 points on Thursday. The Dow traded up 0.30% to 43,539.98 while the NASDAQ rose 0.01% to 18,968.98. The S&P 500 also rose, gaining, 0.17% to 5,926.95. Industrials shares rose by 0.7% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/21/Wall-Street-US-stocks.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.976913"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.145791, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "QUBT", "relevance_score": "0.141726", "ticker_sentiment_score": "0.121598", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVDA", "relevance_score": "0.211191", "ticker_sentiment_score": "0.175574", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.141726", "ticker_sentiment_score": "0.127775", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.211191", "ticker_sentiment_score": "0.240938", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "KURA", "relevance_score": "0.211191", "ticker_sentiment_score": "-0.104728", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNBWF", "relevance_score": "0.071145", "ticker_sentiment_score": "-0.065309", "ticker_sentiment_label": "Neutral"}, {"ticker": "UTI", "relevance_score": "0.141726", "ticker_sentiment_score": "0.4446", "ticker_sentiment_label": "Bullish"}, {"ticker": "KYKOF", "relevance_score": "0.071145", "ticker_sentiment_score": "-0.065309", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Data From Lead Cancer Drug Program In Solid Tumors, Analyst Downgrades As Challenges Remain - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/general/biotech/24/11/42113042/pyxis-oncologys-cancer-drug-progress-stirs-analyst-concerns", "time_published": "20241121T141834", "authors": ["Vandana Singh"], "summary": "On Wednesday, Pyxis Oncology, Inc. PYXS released preliminary data from the ongoing Phase 1 clinical dose escalation study evaluating PYX-201 in multiple solid tumors.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/21/biotech-lab-ai2.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": -0.036273, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.262522", "ticker_sentiment_score": "-0.085333", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Host In-Person  ( NYC )  and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201 - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/11/g41875086/pyxis-oncology-to-host-in-person-nyc-and-virtual-investor-event-on-wednesday-november-20-2024-to-p", "time_published": "20241111T120000", "authors": ["Globe Newswire"], "summary": "BOSTON, Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.00963, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.229582", "ticker_sentiment_score": "-0.010942", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Host In-Person  ( NYC )  and Virtual Investor Event on Wednesday, November 20, 2024, to Present Preliminary Data from the Phase 1 Dose Escalation Trial of PYX-201", "url": "https://www.globenewswire.com/news-release/2024/11/11/2978197/0/en/Pyxis-Oncology-to-Host-In-Person-NYC-and-Virtual-Investor-Event-on-Wednesday-November-20-2024-to-Present-Preliminary-Data-from-the-Phase-1-Dose-Escalation-Trial-of-PYX-201.html", "time_published": "20241111T120000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, Nov. 11, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that it will host an in-person and virtual investor event to discuss preliminary ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.031237, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.152178", "ticker_sentiment_score": "-0.009476", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology's Cancer Drug Platform Shows Potential, Analyst Sees Over 190% Upside - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/general/biotech/24/11/41853605/pyxis-oncologys-cancer-drug-platform-shows-potential-analyst-sees-over-190-upside", "time_published": "20241108T183009", "authors": ["Vandana Singh"], "summary": "Stephens has initiated coverage on Pyxis Oncology Inc PYXS, highlighting the company's technology platform aimed at developing next-gen antibody-drug conjugates ( ADCs ) with enhanced potency, stability, and tolerability.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/11/08/Cancer-Image-by-PDPics-from-Pixabay-.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}], "overall_sentiment_score": 0.234244, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.488007", "ticker_sentiment_score": "0.118179", "ticker_sentiment_label": "Neutral"}]}, {"title": "Aligos Therapeutics Appoints David Perry as Vice President of Business Development", "url": "https://www.globenewswire.com/news-release/2024/10/01/2956026/0/en/Aligos-Therapeutics-Appoints-David-Perry-as-Vice-President-of-Business-Development.html", "time_published": "20241001T120000", "authors": ["Aligos Therapeutics"], "summary": "SOUTH SAN FRANCISCO, Calif., Oct. 01, 2024 ( GLOBE NEWSWIRE ) -- Aligos Therapeutics, Inc. ( Nasdaq: ALGS ) a clinical stage biopharmaceutical company focused on improving patient outcomes through best-in-class therapies for liver and viral diseases, today announced the appointment of David ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/03ffbe89-c47f-4f83-b51f-f13a572e2cd1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.839681"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.170612, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "SGMO", "relevance_score": "0.053992", "ticker_sentiment_score": "0.05095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.213517", "ticker_sentiment_score": "0.157747", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.053992", "ticker_sentiment_score": "0.05095", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOMMF", "relevance_score": "0.053992", "ticker_sentiment_score": "0.036842", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.053992", "ticker_sentiment_score": "0.036842", "ticker_sentiment_label": "Neutral"}]}, {"title": "Bolt Biotherapeutics Announces Changes to its Board of Directors - Bolt Biotherapeutics  ( NASDAQ:BOLT ) ", "url": "https://www.benzinga.com/pressreleases/24/09/g40718039/bolt-biotherapeutics-announces-changes-to-its-board-of-directors", "time_published": "20240904T200500", "authors": ["Globe Newswire"], "summary": "REDWOOD CITY, Calif., Sept. 04, 2024 ( GLOBE NEWSWIRE ) -- Bolt Biotherapeutics BOLT, a clinical-stage biopharmaceutical company developing novel immunotherapies for the treatment of cancer, today announced the appointment of Jakob Dupont, M.D., to its Board of Directors.", "banner_image": "https://ml.globenewswire.com/media/fb5e6ce9-fbe4-4a9b-a822-dac88f68c979/small/bolt-logo-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.202707, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOSS", "relevance_score": "0.114137", "ticker_sentiment_score": "0.002273", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.057215", "ticker_sentiment_score": "0.002001", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.384608", "ticker_sentiment_score": "0.193413", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATRA", "relevance_score": "0.057215", "ticker_sentiment_score": "0.002001", "ticker_sentiment_label": "Neutral"}, {"ticker": "IUGNF", "relevance_score": "0.057215", "ticker_sentiment_score": "0.002001", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Participate in Two Upcoming Investor Conferences - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/08/g40622712/pyxis-oncology-to-participate-in-two-upcoming-investor-conferences", "time_published": "20240829T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. PYXS, a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that Lara S.", "banner_image": "https://ml.globenewswire.com/media/d3b77f06-3f52-42af-8f38-e3fda9c8025b/small/pyxis-logo-jpg.jpg", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.650727"}], "overall_sentiment_score": -0.016788, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.274628", "ticker_sentiment_score": "-0.048397", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.056011", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Participate in Two Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2024/08/29/2937686/0/en/Pyxis-Oncology-to-Participate-in-Two-Upcoming-Investor-Conferences.html", "time_published": "20240829T113000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, Aug. 29, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced that Lara S. Sullivan, M.D., President and Chief Executive Officer, will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.042986, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.181137", "ticker_sentiment_score": "-0.031761", "ticker_sentiment_label": "Neutral"}, {"ticker": "MS", "relevance_score": "0.060848", "ticker_sentiment_score": "0.026999", "ticker_sentiment_label": "Neutral"}]}, {"title": "89bio Appoints Francis Sarena as Chief Operating Officer", "url": "https://www.globenewswire.com/news-release/2024/08/07/2925882/0/en/89bio-Appoints-Francis-Sarena-as-Chief-Operating-Officer.html", "time_published": "20240807T120000", "authors": ["Inc.", "89bio"], "summary": "SAN FRANCISCO, Aug. 07, 2024 ( GLOBE NEWSWIRE ) -- 89bio, Inc. ( Nasdaq: ETNB ) , a clinical-stage biopharmaceutical company focused on the development and commercialization of innovative therapies for the treatment of liver and cardiometabolic diseases, today announced the appointment of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/b9bcc0cc-5a8f-4148-92e4-e6a6ed503a9c", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.275299, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "AMGN", "relevance_score": "0.042196", "ticker_sentiment_score": "0.017635", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.042196", "ticker_sentiment_score": "0.017635", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.43944", "ticker_sentiment_score": "0.334843", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology to Participate in the BTIG Virtual Biotechnology Conference", "url": "https://www.globenewswire.com/news-release/2024/07/29/2920222/0/en/Pyxis-Oncology-to-Participate-in-the-BTIG-Virtual-Biotechnology-Conference.html", "time_published": "20240729T120000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, July 29, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, and members of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.055051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.2035", "ticker_sentiment_score": "-0.040029", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39558985/pyxis-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4", "time_published": "20240628T203000", "authors": ["Globe Newswire"], "summary": "BOSTON, June 28, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}], "overall_sentiment_score": 0.084247, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.644033", "ticker_sentiment_score": "0.10007", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/06/28/2906150/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240628T203000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, June 28, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors granted ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.053212, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.568148", "ticker_sentiment_score": "0.104589", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger - Pyxis Oncology  ( NASDAQ:PYXS ) , Syndax Pharmaceuticals  ( NASDAQ:SNDX ) ", "url": "https://www.benzinga.com/pressreleases/24/06/g39247597/pyxis-oncology-expands-board-of-directors-with-appointment-of-michael-a-metzger", "time_published": "20240610T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, June 10, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: \"PYXS\" ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effective June ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.074051, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRSN", "relevance_score": "0.044222", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.30211", "ticker_sentiment_score": "0.169611", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNDX", "relevance_score": "0.088309", "ticker_sentiment_score": "0.074266", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Expands Board of Directors with Appointment of Michael A. Metzger", "url": "https://www.globenewswire.com/news-release/2024/06/10/2895898/0/en/Pyxis-Oncology-Expands-Board-of-Directors-with-Appointment-of-Michael-A-Metzger.html", "time_published": "20240610T113000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, June 10, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: \"PYXS\" ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Michael A. Metzger to its Board of Directors, effective June ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.05978, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MRSN", "relevance_score": "0.046633", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.27432", "ticker_sentiment_score": "0.163839", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SNDX", "relevance_score": "0.093108", "ticker_sentiment_score": "0.078209", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/05/g39082818/pyxis-oncology-to-participate-in-a-fireside-chat-at-the-jefferies-global-healthcare-conference", "time_published": "20240530T113000", "authors": ["Globe Newswire"], "summary": "BOSTON, May 30, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. PYXS, a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": -0.014408, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.287537", "ticker_sentiment_score": "-0.047847", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Participate in a Fireside Chat at the Jefferies Global Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2024/05/30/2890644/0/en/Pyxis-Oncology-to-Participate-in-a-Fireside-Chat-at-the-Jefferies-Global-Healthcare-Conference.html", "time_published": "20240530T113000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, May 30, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will participate ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.045433, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.190667", "ticker_sentiment_score": "-0.036342", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology, Inc. Reports Q1 Loss, Tops Revenue Estimates - Pyxis Oncology  ( NASDAQ:PYXS ) , Cosmos Health  ( NASDAQ:COSM ) ", "url": "https://www.benzinga.com/news/earnings/24/05/38817785/pyxis-oncology-inc-reports-q1-loss-tops-revenue-estimates", "time_published": "20240514T165158", "authors": ["Zacks"], "summary": "Pyxis Oncology, Inc. PYXS came out with a quarterly loss of $0.06 per share versus the Zacks Consensus Estimate of a loss of $0.27. This compares to loss of $0.54 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/05/14/marcelo-leal-6pcgtjduf6m-unsplash.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.316726"}, {"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.170385, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "COSM", "relevance_score": "0.210579", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.406745", "ticker_sentiment_score": "0.204793", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology, Inc.  ( PYXS )  Reports Q1 Loss, Tops Revenue Estimates", "url": "https://www.zacks.com/stock/news/2273309/pyxis-oncology-inc-pyxs-reports-q1-loss-tops-revenue-estimates", "time_published": "20240514T124003", "authors": ["Zacks Equity Research"], "summary": "Pyxis Oncology (PYXS) delivered earnings and revenue surprises of 77.78% and 279.91%, respectively, for the quarter ended March 2024. Do the numbers hold clues to what lies ahead for the stock?", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default235.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Earnings", "relevance_score": "0.999336"}, {"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.15858, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "COSM", "relevance_score": "0.215574", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.415699", "ticker_sentiment_score": "0.226314", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Does Pyxis Oncology  ( PYXS )  Have the Potential to Rally 61.29% as Wall Street Analysts Expect?", "url": "https://www.zacks.com/stock/news/2254580/does-pyxis-oncology-pyxs-have-the-potential-to-rally-6129-as-wall-street-analysts-expect", "time_published": "20240412T135505", "authors": ["Zacks Equity Research"], "summary": "The average of price targets set by Wall Street analysts indicates a potential upside of 61.3% in Pyxis Oncology (PYXS). While the effectiveness of this highly sought-after metric is questionable, the positive trend in earnings estimate revisions might translate into an upside in the stock.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default105.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.5855"}], "overall_sentiment_score": 0.251522, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.287537", "ticker_sentiment_score": "0.360009", "ticker_sentiment_label": "Bullish"}]}, {"title": "Signet Jewelers, Dave & Buster's Entertainment, Blue Owl Capital And Other Big Stocks Moving Higher On Wednesday - Signet Jewelers  ( NYSE:SIG ) , Dave & Buster's Enter  ( NASDAQ:PLAY ) ", "url": "https://www.benzinga.com/news/24/04/38070966/signet-jewelers-dave-busters-entertainment-blue-owl-capital-and-other-big-stocks-moving-higher-on-we", "time_published": "20240403T143114", "authors": ["Avi Kapoor"], "summary": "U.S. stocks were higher, with the Dow Jones gaining over 50 points on Wednesday. Shares of Signet Jewelers Limited SIG rose sharply during Wednesday's session after the company raised its FY25 guidance.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/04/03/image20.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Energy & Transportation", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.495866"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": 0.376381, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "CALM", "relevance_score": "0.17715", "ticker_sentiment_score": "0.4925", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRCH", "relevance_score": "0.262994", "ticker_sentiment_score": "0.00813", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "OWL", "relevance_score": "0.17715", "ticker_sentiment_score": "0.316704", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GKOS", "relevance_score": "0.262994", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDX", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMTC", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESPR", "relevance_score": "0.17715", "ticker_sentiment_score": "0.472246", "ticker_sentiment_label": "Bullish"}, {"ticker": "SIG", "relevance_score": "0.262994", "ticker_sentiment_score": "0.170854", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SMXT", "relevance_score": "0.17715", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLAY", "relevance_score": "0.17715", "ticker_sentiment_score": "0.399271", "ticker_sentiment_label": "Bullish"}, {"ticker": "DXYZ", "relevance_score": "0.17715", "ticker_sentiment_score": "0.375202", "ticker_sentiment_label": "Bullish"}, {"ticker": "OBDC", "relevance_score": "0.089129", "ticker_sentiment_score": "0.23393", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ALTM", "relevance_score": "0.17715", "ticker_sentiment_score": "0.55146", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCGN", "relevance_score": "0.262994", "ticker_sentiment_score": "0.326741", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ZIM", "relevance_score": "0.17715", "ticker_sentiment_score": "0.472246", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37995445/pyxis-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4", "time_published": "20240328T203000", "authors": ["Globe Newswire"], "summary": "BOSTON, March 28, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}], "overall_sentiment_score": 0.084247, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.645887", "ticker_sentiment_score": "0.100208", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2024/03/28/2854505/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20240328T203000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, March 28, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors granted ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.053212, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.570165", "ticker_sentiment_score": "0.104789", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37954843/pyxis-oncology-obtains-8-million-payment-for-the-sale-of-royalty-rights", "time_published": "20240327T113000", "authors": ["Globe Newswire"], "summary": "Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate ( ADC ) asset, PYX-201 Pyxis Oncology retains rights to three other antibodies in development by Apexigen's licensees discovered through the APXiMAB platform", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.176341, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.799855", "ticker_sentiment_score": "0.200309", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Obtains $8 Million Payment for the Sale of Royalty Rights", "url": "https://www.globenewswire.com/news-release/2024/03/27/2853057/0/en/Pyxis-Oncology-Obtains-8-Million-Payment-for-the-Sale-of-Royalty-Rights.html", "time_published": "20240327T113000", "authors": ["Pyxis Oncology"], "summary": "Non-dilutive funding to support development of first-in-concept lead Antibody-Drug Conjugate ( ADC ) asset, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.038432, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.495015", "ticker_sentiment_score": "0.168191", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "All You Need to Know About Pyxis Oncology  ( PYXS )  Rating Upgrade to Buy", "url": "https://www.zacks.com/stock/news/2246219/all-you-need-to-know-about-pyxis-oncology-pyxs-rating-upgrade-to-buy", "time_published": "20240326T160010", "authors": ["Zacks Equity Research"], "summary": "Pyxis Oncology (PYXS) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 (Buy).", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default262.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.692272"}], "overall_sentiment_score": 0.298498, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.362505", "ticker_sentiment_score": "0.322222", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Why FedEx Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket - FedEx  ( NYSE:FDX ) ", "url": "https://www.benzinga.com/news/24/03/37889416/why-fedex-shares-are-trading-higher-by-around-12-here-are-20-stocks-moving-premarket", "time_published": "20240322T121057", "authors": ["Avi Kapoor"], "summary": "Shares of FedEx Corporation FDX rose sharply in today's pre-market trading after the company reported better-than-expected earnings for its third quarter and authorized a new $5 billion share repurchase program.", "banner_image": "https://cdn.benzinga.com/files/images/story/2024/03/22/image11.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.882182"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.9545"}], "overall_sentiment_score": 0.154651, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.230264", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BEAT", "relevance_score": "0.151539", "ticker_sentiment_score": "0.154644", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NKE", "relevance_score": "0.151539", "ticker_sentiment_score": "0.120233", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNA", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.240485", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SUGP", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.155731", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ASST", "relevance_score": "0.2256", "ticker_sentiment_score": "0.129929", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPR", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.255791", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JOAN", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.060728", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRDI", "relevance_score": "0.151539", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.181582", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BIOL", "relevance_score": "0.151539", "ticker_sentiment_score": "0.355506", "ticker_sentiment_label": "Bullish"}, {"ticker": "FDX", "relevance_score": "0.297661", "ticker_sentiment_score": "0.301816", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WS", "relevance_score": "0.151539", "ticker_sentiment_score": "0.146943", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTC", "relevance_score": "0.151539", "ticker_sentiment_score": "0.141226", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABTS", "relevance_score": "0.151539", "ticker_sentiment_score": "-0.22515", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NVFY", "relevance_score": "0.151539", "ticker_sentiment_score": "0.213634", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "OCGN", "relevance_score": "0.2256", "ticker_sentiment_score": "0.318714", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Provides Corporate Update and Reports Financial Results for Fourth Quarter and Full Year 2023", "url": "https://www.globenewswire.com/news-release/2024/03/21/2850125/0/en/Pyxis-Oncology-Provides-Corporate-Update-and-Reports-Financial-Results-for-Fourth-Quarter-and-Full-Year-2023.html", "time_published": "20240321T113000", "authors": ["Pyxis Oncology"], "summary": "PYX-201 Phase 1 Part 1 trial progressing with initial data expected in the fall of ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/3398f0ee-af74-4ddf-bf2e-bd03dc29ccdb/Picture1.jpg", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.94762"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Blockchain", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.023978, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.212814", "ticker_sentiment_score": "0.013561", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Expands Board of Directors with Appointment of Santhosh Palani, Ph.D., CFA", "url": "https://www.globenewswire.com/news-release/2024/03/13/2845349/0/en/Pyxis-Oncology-Expands-Board-of-Directors-with-Appointment-of-Santhosh-Palani-Ph-D-CFA.html", "time_published": "20240313T120000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, March 13, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: \"PYXS\" ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, today announced the appointment of Santhosh Palani, Ph.D., CFA, to its board of directors, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}], "overall_sentiment_score": 0.071635, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "HESG", "relevance_score": "0.0428", "ticker_sentiment_score": "0.019547", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.25255", "ticker_sentiment_score": "0.171267", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.0428", "ticker_sentiment_score": "0.019547", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Present at Leerink Global Biopharma Conference 2024", "url": "https://www.globenewswire.com/news-release/2024/03/07/2842790/0/en/Pyxis-Oncology-to-Present-at-Leerink-Global-Biopharma-Conference-2024.html", "time_published": "20240307T213000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, March 07, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next generation therapeutics to target difficult-to-treat cancers, announced today that Lara S. Sullivan, M.D., President and Chief Executive Officer, will ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.04296, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.179343", "ticker_sentiment_score": "-0.034747", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/24/03/g37495724/pyxis-oncology-to-present-new-pyx-201-pyx-106-and-pyx-102-preclinical-data-at-aacr-annual-meeting", "time_published": "20240305T214500", "authors": ["Globe Newswire"], "summary": "PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models The PYX-201 target EDB+FN is found overexpressed across multiple human solid tumor types BOSTON, March 05, 2024 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.009768, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.346365", "ticker_sentiment_score": "0.080647", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Present New PYX-201, PYX-106 and PYX-102 Preclinical Data at AACR Annual Meeting", "url": "https://www.globenewswire.com/news-release/2024/03/05/2840966/0/en/Pyxis-Oncology-to-Present-New-PYX-201-PYX-106-and-PYX-102-Preclinical-Data-at-AACR-Annual-Meeting.html", "time_published": "20240305T214500", "authors": ["Pyxis Oncology"], "summary": "PYX-201, an EDB+FN-specific tumor stroma-targeting ADC, demonstrates potent anti-tumor efficacy across multiple human cancers in PDX tumor models ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": -0.021734, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.189076", "ticker_sentiment_score": "0.037965", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/12/29/2802172/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20231229T213000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, Dec. 29, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors approved a ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.972756"}], "overall_sentiment_score": 0.182196, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.601928", "ticker_sentiment_score": "0.246182", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/12/g36434527/pyxis-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4", "time_published": "20231229T213000", "authors": ["Globe Newswire"], "summary": "BOSTON, Dec. 29, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.986714"}], "overall_sentiment_score": 0.165364, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.576289", "ticker_sentiment_score": "0.223647", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dianthus Therapeutics Enhances Leadership Team with Appointment of Jeffrey Stavenhagen, Ph.D., as Chief Scientific Officer - Dianthus Therapeutics  ( NASDAQ:DNTH ) ", "url": "https://www.benzinga.com/pressreleases/23/11/g36011541/dianthus-therapeutics-enhances-leadership-team-with-appointment-of-jeffrey-stavenhagen-ph-d-as-chi", "time_published": "20231129T210500", "authors": ["Globe Newswire"], "summary": "Dr. Stavenhagen brings over 20 years of experience in leading drug discovery initiatives, with a focus on monoclonal antibodies targeting neuro diseases Jennifer Davis Ruff also named Vice President, Head of Investor Relations & Corporate Affairs with over 20 years of experience at leading public ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.146702, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MGNX", "relevance_score": "0.032691", "ticker_sentiment_score": "0.08573", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.032691", "ticker_sentiment_score": "-0.053857", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNTH", "relevance_score": "0.097854", "ticker_sentiment_score": "0.15058", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.032691", "ticker_sentiment_score": "-0.053857", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Initiatives to Prioritize Lead ADC Program; Reports Financial Results for Third-Quarter 2023 and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/11/07/2775688/0/en/Pyxis-Oncology-Announces-Initiatives-to-Prioritize-Lead-ADC-Program-Reports-Financial-Results-for-Third-Quarter-2023-and-Provides-Corporate-Update.html", "time_published": "20231107T213000", "authors": ["Pyxis Oncology"], "summary": "PYX-201 ( a novel first-in-concept and first-in-class tumor stroma targeting antibody-drug conjugate [ADC] product candidate ) Phase 1 trial progressing with fifth dose cohort at 3.6 mg/kg. data expected 1H 2024.", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.955357"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.538269"}, {"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.099695, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.298264", "ticker_sentiment_score": "0.141962", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc.  ( NASDAQ: PYXS )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/10/g35448465/shareholder-alert-levi-korsinsky-llp-notifies-shareholders-of-an-investigation-concerning-possible", "time_published": "20231026T182722", "authors": ["Globe Newswire"], "summary": "NEW YORK, Oct. 26, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. PYXS concerning possible breaches of fiduciary duty. To obtain additional information, go to: or contact Joseph E.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": -0.076243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.42503", "ticker_sentiment_score": "-0.155454", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Inspiring the Next Generation of Entrepreneurs at the Diversity and Equity Accelerator through Learning for Startups  ( DEALS )  Workshop", "url": "https://www.prnewswire.com/news-releases/inspiring-the-next-generation-of-entrepreneurs-at-the-diversity-and-equity-accelerator-through-learning-for-startups-deals-workshop-301964671.html", "time_published": "20231023T152700", "authors": ["Bwise"], "summary": "Inspiring the Next Generation of Entrepreneurs at the Diversity and Equity Accelerator through Learning for Startups ... PR ...", "banner_image": "https://mma.prnewswire.com/media/2254802/Bwise_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Energy & Transportation", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.316726"}], "overall_sentiment_score": 0.365893, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.041938", "ticker_sentiment_score": "0.166888", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "XOM", "relevance_score": "0.020976", "ticker_sentiment_score": "0.136344", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer  ( SITC )  2023 - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/09/g34948637/pyxis-oncology-announces-four-abstracts-accepted-for-poster-presentation-at-society-for-immunother", "time_published": "20230927T131858", "authors": ["Globe Newswire"], "summary": "BOSTON, Sept. 27, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.165412, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.061315", "ticker_sentiment_score": "0.15213", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.409742", "ticker_sentiment_score": "0.091567", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Four Abstracts Accepted for Poster Presentation at Society for Immunotherapy of Cancer  ( SITC )  2023", "url": "https://www.globenewswire.com/news-release/2023/09/27/2750495/0/en/Pyxis-Oncology-Announces-Four-Abstracts-Accepted-for-Poster-Presentation-at-Society-for-Immunotherapy-of-Cancer-SITC-2023.html", "time_published": "20230927T131800", "authors": ["Pyxis Oncology"], "summary": "BOSTON, Sept. 27, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced four abstracts for four different assets have been accepted for poster ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.062817, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.041755", "ticker_sentiment_score": "0.14953", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.246582", "ticker_sentiment_score": "0.066611", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology M&A Spotlight Signals Potential Growth Amidst Competitive ADC Landscape: Analyst - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/general/biotech/23/09/34244004/pyxis-oncology-m-a-spotlight-signals-potential-growth-amidst-competitive-adc-landscape-analyst", "time_published": "20230905T164314", "authors": ["Vandana Singh"], "summary": "RBC Capital Markets has initiated coverage on Pyxis Oncology Inc PYXS with an Outperform rating and a price target of $7. Last month, Pyxis Oncology acquired Apexigen Inc., focused on discovering and developing antibody therapeutics for oncology, in an all-stock transaction valued at ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/09/05/pyxs.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.266143"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.387536, "overall_sentiment_label": "Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.140896", "ticker_sentiment_score": "0.255407", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.522333", "ticker_sentiment_score": "0.502502", "ticker_sentiment_label": "Bullish"}, {"ticker": "SGEN", "relevance_score": "0.277433", "ticker_sentiment_score": "0.087105", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.405651", "ticker_sentiment_score": "0.524373", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pyxis Oncology Successfully Completes Acquisition of Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/08/g34002489/pyxis-oncology-successfully-completes-acquisition-of-apexigen", "time_published": "20230823T123500", "authors": ["Globe Newswire"], "summary": "Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream Company positioned as a leader in next-generation, end-to-end Antibody-Drug Conjugate ( \"ADC\" ) creation with clinically and commercially validated platform capabilities", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "1.0"}], "overall_sentiment_score": 0.165684, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.288214", "ticker_sentiment_score": "0.192514", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOSS", "relevance_score": "0.029472", "ticker_sentiment_score": "-0.086323", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.470048", "ticker_sentiment_score": "0.308008", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATRA", "relevance_score": "0.029472", "ticker_sentiment_score": "-0.086323", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.029472", "ticker_sentiment_score": "0.198825", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Successfully Completes Acquisition of Apexigen", "url": "https://www.globenewswire.com/news-release/2023/08/23/2730427/0/en/Pyxis-Oncology-Successfully-Completes-Acquisition-of-Apexigen.html", "time_published": "20230823T123500", "authors": ["Pyxis Oncology"], "summary": "Transaction adds a validated antibody-discovery platform, Phase 2 candidate and royalty stream ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}], "overall_sentiment_score": 0.161228, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.298023", "ticker_sentiment_score": "0.19773", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GOSS", "relevance_score": "0.030524", "ticker_sentiment_score": "-0.086771", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.459624", "ticker_sentiment_score": "0.298672", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ATRA", "relevance_score": "0.030524", "ticker_sentiment_score": "-0.086771", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.030524", "ticker_sentiment_score": "0.186808", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Down -15.56% in 4 Weeks, Here's Why You Should You Buy the Dip in Pyxis Oncology, Inc.  ( PYXS ) ", "url": "https://www.zacks.com/stock/news/2138631/down--1556-in-4-weeks-heres-why-you-should-you-buy-the-dip-in-pyxis-oncology-inc-pyxs", "time_published": "20230821T133505", "authors": ["Zacks Equity Research"], "summary": "Pyxis Oncology, Inc. (PYXS) has become technically an oversold stock now, which implies exhaustion of the heavy selling pressure on it. This, combined with strong agreement among Wall Street analysts in revising earnings estimates higher, indicates a potential trend reversal for the stock in the ...", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default313.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.818451"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.990999"}], "overall_sentiment_score": 0.210935, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.485711", "ticker_sentiment_score": "0.293551", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates AVID, CPRI, APGN", "url": "https://www.prnewswire.com/news-releases/shareholder-investigation-halper-sadeh-llc-investigates-avid-cpri-apgn-301898917.html", "time_published": "20230811T185900", "authors": ["Halper Sadeh LLP"], "summary": "NEW YORK, Aug. 11, 2023 /PRNewswire/ -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: sale to an affiliate of STG for $27.05 in cash ...", "banner_image": "https://mma.prnewswire.com/media/1896150/Firm_Logo_with_Investor_Law_Firm_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Manufacturing", "relevance_score": "0.5"}], "overall_sentiment_score": 0.216515, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.353059", "ticker_sentiment_score": "0.331957", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.181137", "ticker_sentiment_score": "0.20115", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TPR", "relevance_score": "0.181137", "ticker_sentiment_score": "0.120649", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Financial Results for Second-Quarter 2023 and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/08/11/2723437/0/en/Pyxis-Oncology-Reports-Financial-Results-for-Second-Quarter-2023-and-Provides-Corporate-Update.html", "time_published": "20230811T110000", "authors": ["Pyxis Oncology"], "summary": "Third dose cohort initiated in Phase 1 trial of PYX-201, Pyxis Oncology's first ADC product candidate ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/d3b77f06-3f52-42af-8f38-e3fda9c8025b", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.98396"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.066519, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.051551", "ticker_sentiment_score": "0.01698", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.179027", "ticker_sentiment_score": "0.013324", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology, Inc.  ( PYXS )  Upgraded to Strong Buy: What Does It Mean for the Stock?", "url": "https://www.zacks.com/stock/news/2122285/pyxis-oncology-inc-pyxs-upgraded-to-strong-buy-what-does-it-mean-for-the-stock", "time_published": "20230717T160006", "authors": ["Zacks Investment Research"], "summary": "Pyxis Oncology, Inc. (PYXS) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default286.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.997845"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.658903"}], "overall_sentiment_score": 0.318724, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.356438", "ticker_sentiment_score": "0.338523", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "CancerVAX CEO Ryan Davies Discusses Biotech Entrepreneurship with Pyxis Oncology CEO Dr. Lara Sullivan", "url": "https://www.benzinga.com/pressreleases/23/07/g33159728/cancervax-ceo-ryan-davies-discusses-biotech-entrepreneurship-with-pyxis-oncology-ceo-dr-lara-sulli", "time_published": "20230710T070100", "authors": ["Globe Newswire"], "summary": "LEHI, Utah, July 10, 2023 ( GLOBE NEWSWIRE ) -- CancerVAX, Inc., developer of a breakthrough universal cancer vaccine that uses the body's immune system to fight cancer, today announced that in a recent Company podcast its CEO, Ryan Davies, and Pyxis Oncology President & CEO, Dr. Lara Sullivan, ...", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": -0.104089, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.168099", "ticker_sentiment_score": "0.007122", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.328819", "ticker_sentiment_score": "0.118708", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.056407", "ticker_sentiment_score": "0.038", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/06/30/2698101/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20230630T210000", "authors": ["Pyxis Oncology"], "summary": "BOSTON, June 30, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors granted ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.103345, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.636698", "ticker_sentiment_score": "0.215033", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g33086117/pyxis-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635-c-4", "time_published": "20230630T210000", "authors": ["Globe Newswire"], "summary": "BOSTON, June 30, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.997405"}], "overall_sentiment_score": 0.095808, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.617765", "ticker_sentiment_score": "0.197441", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Tagworks Pharmaceuticals Announces $65 Million in Series A Financing to Advance Click-to-Release Therapeutics", "url": "https://www.prnewswire.com/apac/news-releases/tagworks-pharmaceuticals-announces-65-million-in-series-a-financing-to-advance-click-to-release-therapeutics-301858150.html", "time_published": "20230622T135300", "authors": ["Tagworks Pharmaceuticals BV"], "summary": "Financing round led by Ysios Capital and Gilde Healthcare with participation from Novartis Venture Fund, New Enterprise Associates, and Lightstone Ventures Unique Click-to-Release platform enables on-target activation of antibody-drug conjugates ( ADCs ) and immunomodulators, as well as ...", "banner_image": "https://mma.prnewswire.com/media/2107979/Tagworks_Pharmaceuticals_BV_Logo.jpg?p=facebook", "source": "PR Newswire", "category_within_source": "n/a", "source_domain": "www.prnewswire.com", "topics": [{"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}], "overall_sentiment_score": 0.266291, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.02674", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADCT", "relevance_score": "0.053449", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates APGN, KBNT, DM, WTT - Apexigen  ( NASDAQ:APGN ) , Desktop Metal  ( NYSE:DM ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g32705988/shareholder-investigation-halper-sadeh-llc-investigates-apgn-kbnt-dm-wtt", "time_published": "20230604T124011", "authors": ["Globe Newswire"], "summary": "NEW YORK, June 04, 2023 ( GLOBE NEWSWIRE ) -- Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws and/or breaches of fiduciary duties to shareholders relating to: Apexigen, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}], "overall_sentiment_score": 0.118488, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.359014", "ticker_sentiment_score": "0.317771", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DM", "relevance_score": "0.465901", "ticker_sentiment_score": "0.237177", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.123526", "ticker_sentiment_score": "0.151639", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "SSYS", "relevance_score": "0.244109", "ticker_sentiment_score": "0.146439", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.359014", "ticker_sentiment_score": "0.203024", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Lifshitz Law PLLC Announces Investigations of APGN, GNL, RTL, and BACK - Apexigen  ( NASDAQ:APGN ) , IMAC Hldgs  ( NASDAQ:BACK ) ", "url": "https://www.benzinga.com/pressreleases/23/06/g32704776/lifshitz-law-pllc-announces-investigations-of-apgn-gnl-rtl-and-back", "time_published": "20230604T001700", "authors": ["Globe Newswire"], "summary": "NEW YORK, June 03, 2023 ( GLOBE NEWSWIRE ) -- Lifshitz Law PLLC announces an investigation into possible breach of fiduciary duties in connection with the merger of APGN and Pyxis Oncology, Inc.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Real Estate & Construction", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999767"}], "overall_sentiment_score": 0.197703, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.370418", "ticker_sentiment_score": "0.230534", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BACK", "relevance_score": "0.300394", "ticker_sentiment_score": "0.20583", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.152983", "ticker_sentiment_score": "0.096184", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNL", "relevance_score": "0.370418", "ticker_sentiment_score": "0.203737", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "THER", "relevance_score": "0.152983", "ticker_sentiment_score": "0.101741", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis  ( PYXS )  Up on Advancing Cancer Therapy Candidates", "url": "https://www.zacks.com/stock/news/2101934/pyxis-pyxs-up-on-advancing-cancer-therapy-candidates", "time_published": "20230531T133900", "authors": ["Zacks Investment Research"], "summary": "Pyxis' (PYXS) shares rise as the company advances its phase I candidates, PYX-106 and PYX-201, for challenging cancer therapies.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/f5/284.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.173724, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.258351", "ticker_sentiment_score": "0.193029", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADMA", "relevance_score": "0.417304", "ticker_sentiment_score": "0.138829", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.490323", "ticker_sentiment_score": "0.276839", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.258351", "ticker_sentiment_score": "0.204503", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Apexigen  ( APGN )  to Get Acquired by Pyxis Oncology, Stock Up", "url": "https://www.zacks.com/stock/news/2099939/apexigen-apgn-to-get-acquired-by-pyxis-oncology-stock-up", "time_published": "20230525T192500", "authors": ["Zacks Investment Research"], "summary": "Apexigen (APGN) surges as Pyxis Oncology offers to acquire it for approximately $16 million.", "banner_image": "https://staticx-tuner.zacks.com/images/articles/main/57/40404.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.156659, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.795061", "ticker_sentiment_score": "0.310487", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ADMA", "relevance_score": "0.402618", "ticker_sentiment_score": "0.135402", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.47379", "ticker_sentiment_score": "0.477146", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.084127", "ticker_sentiment_score": "0.03958", "ticker_sentiment_label": "Neutral"}]}, {"title": "Moore Kuehn Encourages CWBR, RXDX, RUTH, and APGN Investors to Contact Law Firm - Apexigen  ( NASDAQ:APGN ) , CohBar  ( NASDAQ:CWBR ) ", "url": "https://www.benzinga.com/pressreleases/23/05/g32578713/moore-kuehn-encourages-cwbr-rxdx-ruth-and-apgn-investors-to-contact-law-firm", "time_published": "20230525T155102", "authors": ["Globe Newswire"], "summary": "NEW YORK, May 25, 2023 ( GLOBE NEWSWIRE ) -- Moore Kuehn, PLLC, a law firm focusing in securities litigation located on Wall Street in downtown New York City, is investigating potential claims concerning whether the following proposed mergers are fair to shareholders.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Retail & Wholesale", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.177462, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.109956", "ticker_sentiment_score": "-0.026333", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.109956", "ticker_sentiment_score": "0.292049", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RUTH", "relevance_score": "0.109956", "ticker_sentiment_score": "0.212275", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "APGN", "relevance_score": "0.217834", "ticker_sentiment_score": "0.425596", "ticker_sentiment_label": "Bullish"}, {"ticker": "DRI", "relevance_score": "0.109956", "ticker_sentiment_score": "0.212275", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CWBR", "relevance_score": "0.217834", "ticker_sentiment_score": "0.15023", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "RXDX", "relevance_score": "0.217834", "ticker_sentiment_score": "0.28997", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Small SPAC Biotech Apexigen To Be Acquired Pyxis Oncology For $16M - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/general/biotech/23/05/32554799/small-spac-biotech-apexigen-to-be-acquired-pyxis-oncology-for-16m", "time_published": "20230524T182848", "authors": ["Vandana Singh"], "summary": "Pyxis Oncology Inc PYXS agreed to acquire Apexigen Inc APGN in an all-stock transaction for an implied value of $0.64 per Apexigen share. Apexigen went public in a blank-check deal just last summer.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/05/24/aapharma_3.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.858979"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.2459, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.803061", "ticker_sentiment_score": "0.517892", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.947069", "ticker_sentiment_score": "0.485331", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.371523", "ticker_sentiment_score": "0.254431", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Bolsters Oncology Portfolio Through $16M Apexigen Acquisition - Pyxis Oncology  ( NASDAQ:PYXS ) , Apexigen  ( NASDAQ:APGN ) ", "url": "https://www.benzinga.com/m-a/23/05/32554632/pyxis-oncology-bolsters-oncology-portfolio-through-16m-apexigen-acquisition", "time_published": "20230524T161915", "authors": ["Benzinga Insights"], "summary": "Pyxis Oncology PYXS has announced an acquisition of Apexigen APGN that is expected to be completed in the second half of 2023. Under the terms of the agreement, Pyxis Oncology has agreed to give Apexigen $16 million in stock in exchange for APGN stock.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/ma_image_4.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Mergers & Acquisitions", "relevance_score": "0.576289"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.091804, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.616842", "ticker_sentiment_score": "0.129721", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.514619", "ticker_sentiment_score": "-0.036889", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Acquire Apexigen - Pyxis Oncology  ( NASDAQ:PYXS ) , Apexigen  ( NASDAQ:APGN ) ", "url": "https://www.benzinga.com/pressreleases/23/05/g32547139/pyxis-oncology-to-acquire-apexigen", "time_published": "20230524T104500", "authors": ["Globe Newswire"], "summary": "Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate ( ADC ) development Commercially and clinically validated APXiMAB platform for antibody generation complements FACT ADC toolkit of linkers, payloads and conjugation chemistries previously obtained from Pfizer", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Mergers", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999696"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.239703, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.419153", "ticker_sentiment_score": "0.366632", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.495342", "ticker_sentiment_score": "0.384211", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.0367", "ticker_sentiment_score": "0.140027", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Acquire Apexigen", "url": "https://www.globenewswire.com/news-release/2023/05/24/2675054/0/en/Pyxis-Oncology-to-Acquire-Apexigen.html", "time_published": "20230524T104500", "authors": ["Pyxis Oncology"], "summary": "Pyxis Oncology positioned at forefront of Antibody-Drug Conjugate ( ADC ) development ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.999819"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.714479"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.21517, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "APGN", "relevance_score": "0.323078", "ticker_sentiment_score": "0.30939", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.417161", "ticker_sentiment_score": "0.344115", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PFE", "relevance_score": "0.030216", "ticker_sentiment_score": "0.127603", "ticker_sentiment_label": "Neutral"}]}, {"title": "Is Clover Health Investments  ( CLOV )  Stock Outpacing Its Medical Peers This Year?", "url": "https://www.zacks.com/stock/news/2097339/is-clover-health-investments-clov-stock-outpacing-its-medical-peers-this-year", "time_published": "20230519T134012", "authors": ["Zacks Investment Research"], "summary": "Here is how Clover Health Investments, Corp. (CLOV) and Pyxis Oncology, Inc. (PYXS) have performed compared to their sector so far this year.", "banner_image": "https://staticx-tuner.zacks.com/images/default_article_images/default299.jpg", "source": "Zacks Commentary", "category_within_source": "n/a", "source_domain": "www.zacks.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.503496"}, {"topic": "Earnings", "relevance_score": "0.614606"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Finance", "relevance_score": "0.5"}], "overall_sentiment_score": 0.202018, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.466325", "ticker_sentiment_score": "0.227316", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CLOV", "relevance_score": "0.737428", "ticker_sentiment_score": "0.308163", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "3 Top Penny Stocks To Watch As GSIT, OMH Stock Explode", "url": "https://pennystocks.com/featured/2023/05/15/3-top-penny-stocks-to-watch-gsit-omh-stock-explode/", "time_published": "20230515T170303", "authors": ["J. Phillip"], "summary": "Penny stocks are sought after for their potential to explode to extreme levels. Look at a company we discussed roughly one month ago, Ohmyhome Ltd ( NASDAQ: OMH ) . In the article 3 Hot Penny Stocks To Watch Today. Is It Time To Buy? OMH stock was discussed shortly after the company made its ...", "banner_image": null, "source": "PennyStocks.com", "category_within_source": "n/a", "source_domain": "pennystocks.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.795202"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.162434, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.116536", "ticker_sentiment_score": "0.109224", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOUN", "relevance_score": "0.116536", "ticker_sentiment_score": "0.157951", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "GSIT", "relevance_score": "0.116536", "ticker_sentiment_score": "0.06472", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMH", "relevance_score": "0.154951", "ticker_sentiment_score": "0.016441", "ticker_sentiment_label": "Neutral"}, {"ticker": "GETR", "relevance_score": "0.267664", "ticker_sentiment_score": "0.13775", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYREQ", "relevance_score": "0.116536", "ticker_sentiment_score": "0.088158", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.116536", "ticker_sentiment_score": "0.066961", "ticker_sentiment_label": "Neutral"}]}, {"title": "Impel Pharmaceuticals Announces Appointment of Darren Cline to the Board of Directors - Impel Pharmaceuticals  ( NASDAQ:IMPL ) ", "url": "https://www.benzinga.com/pressreleases/23/04/g31776707/impel-pharmaceuticals-announces-appointment-of-darren-cline-to-the-board-of-directors", "time_published": "20230412T200100", "authors": ["Globe Newswire"], "summary": "SEATTLE, April 12, 2023 ( GLOBE NEWSWIRE ) -- Impel Pharmaceuticals IMPL, a commercial-stage pharmaceutical company developing transformative therapies for people suffering from diseases with high unmet medical needs, today announced the appointment of Darren Cline to the Board of Directors.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.495866"}], "overall_sentiment_score": 0.112744, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.027413", "ticker_sentiment_score": "0.0082", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMPL", "relevance_score": "0.163354", "ticker_sentiment_score": "0.119269", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGEN", "relevance_score": "0.054794", "ticker_sentiment_score": "0.008984", "ticker_sentiment_label": "Neutral"}, {"ticker": "JAZZ", "relevance_score": "0.027413", "ticker_sentiment_score": "0.0082", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.027413", "ticker_sentiment_score": "0.0082", "ticker_sentiment_label": "Neutral"}]}, {"title": "SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Pyxis Oncology, Inc.  ( NASDAQ:PYXS )  - Pyxis Oncology  ( NASDAQ:PYXS ) ", "url": "https://www.benzinga.com/pressreleases/23/04/g31687066/shareholder-alert-levi-korsinsky-llp-notifies-shareholders-of-an-investigation-concerning-possible", "time_published": "20230405T200238", "authors": ["Globe Newswire"], "summary": "NEW YORK, April 05, 2023 ( GLOBE NEWSWIRE ) -- Levi & Korsinsky announces that it has commenced an investigation of Pyxis Oncology, Inc. PYXS concerning possible breaches of fiduciary duty. To obtain additional information, go to: or contact Joseph E.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": -0.076243, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.42503", "ticker_sentiment_score": "-0.155454", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why Chicken Soup For The Soul Entertainment Shares Are Trading Higher By 14%; Here Are 20 Stocks Moving Premarket - Bullfrog AI Hldgs  ( NASDAQ:BFRG ) , Addex Therapeutics  ( NASDAQ:ADXN ) ", "url": "https://www.benzinga.com/news/23/04/31676812/why-chicken-soup-for-the-soul-entertainment-shares-are-trading-higher-by-14-here-are-20-stocks-movin", "time_published": "20230405T121611", "authors": ["Lisa Levin"], "summary": "RiceBran Technologies RIBT gained 43.1% to $1.33 in pre-market trading after gaining 3% on Tuesday. Addex Therapeutics Ltd ADXN jumped 35.4% to $1.25 in pre-market trading. Addex said it completed $5 million equity financing.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/04/05/chicken_soup_for_the_soul_entertainment_-_logo_copy.jpg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.25"}, {"topic": "Earnings", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.067828, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRDS", "relevance_score": "0.208764", "ticker_sentiment_score": "0.265451", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.140076", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRI", "relevance_score": "0.140076", "ticker_sentiment_score": "-0.120818", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRG", "relevance_score": "0.208764", "ticker_sentiment_score": "0.085155", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.140076", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.208764", "ticker_sentiment_score": "0.329155", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IONM", "relevance_score": "0.208764", "ticker_sentiment_score": "-0.206379", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "NFTG", "relevance_score": "0.208764", "ticker_sentiment_score": "0.081083", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIBT", "relevance_score": "0.140076", "ticker_sentiment_score": "0.378211", "ticker_sentiment_label": "Bullish"}, {"ticker": "SPPI", "relevance_score": "0.140076", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVVE", "relevance_score": "0.208764", "ticker_sentiment_score": "0.234783", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ONCT", "relevance_score": "0.208764", "ticker_sentiment_score": "-0.21469", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SECO", "relevance_score": "0.140076", "ticker_sentiment_score": "-0.334928", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FWBI", "relevance_score": "0.208764", "ticker_sentiment_score": "0.256088", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "EBON", "relevance_score": "0.140076", "ticker_sentiment_score": "0.204349", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSSE", "relevance_score": "0.140076", "ticker_sentiment_score": "0.204349", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2023/03/31/2639062/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20230331T210000", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., March 31, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical-stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported today that Pyxis Oncology's Compensation Committee of the Board of Directors ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.105712, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.634282", "ticker_sentiment_score": "0.214612", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Dow Jumps Over 150 Points; US Core PCE Price Inflation Eases - Gorilla Technology Gr  ( NASDAQ:GRRR ) , Chicken Soup for the Soul  ( NASDAQ:CSSE ) ", "url": "https://www.benzinga.com/news/earnings/23/03/31609911/dow-jumps-over-150-points-us-core-pce-price-inflation-eases", "time_published": "20230331T142529", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones jumping more than 150 points on Friday. The Dow traded up 0.56% to 33,042.24 while the NASDAQ rose 0.55% to 12,079.22. The S&P 500, also rose, gaining, 0.50% to 4,071.28. Consumer discretionary shares jumped by 1.1% on Thursday.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/31/image23.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Markets", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Economy - Monetary", "relevance_score": "0.838487"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Economy - Fiscal", "relevance_score": "0.158519"}, {"topic": "Financial Markets", "relevance_score": "0.684621"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Real Estate & Construction", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.084209, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "NAAS", "relevance_score": "0.122269", "ticker_sentiment_score": "0.1763", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.182506", "ticker_sentiment_score": "-0.11762", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRRR", "relevance_score": "0.122269", "ticker_sentiment_score": "0.307568", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "IONQ", "relevance_score": "0.122269", "ticker_sentiment_score": "0.42586", "ticker_sentiment_label": "Bullish"}, {"ticker": "YMAB", "relevance_score": "0.122269", "ticker_sentiment_score": "0.277697", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CSSE", "relevance_score": "0.122269", "ticker_sentiment_score": "0.075175", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.122269", "ticker_sentiment_score": "0.1763", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TORO", "relevance_score": "0.122269", "ticker_sentiment_score": "0.44045", "ticker_sentiment_label": "Bullish"}]}, {"title": "Top 5 Health Care Stocks That May Collapse - Accelerate Diagnostics  ( NASDAQ:AXDX ) , Achieve Life Sciences  ( NASDAQ:ACHV ) ", "url": "https://www.benzinga.com/news/23/03/31608382/top-5-health-care-stocks-that-may-collapse", "time_published": "20230331T131018", "authors": ["Lisa Levin"], "summary": "The most overbought stocks in the health care sector presents an opportunity to go short on these overvalued companies. The RSI is a momentum indicator, which compares a stock's strength on days when prices go up to its strength on days when prices go down.", "banner_image": "https://www.benzinga.com/next-assets/images/schema-image-default.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}, {"topic": "Earnings", "relevance_score": "0.360215"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.334836, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.359447", "ticker_sentiment_score": "0.20147", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PALI", "relevance_score": "0.273807", "ticker_sentiment_score": "0.305148", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "AXDX", "relevance_score": "0.359447", "ticker_sentiment_score": "0.582847", "ticker_sentiment_label": "Bullish"}, {"ticker": "OSH", "relevance_score": "0.273807", "ticker_sentiment_score": "0.314492", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "ACHV", "relevance_score": "0.273807", "ticker_sentiment_score": "0.126337", "ticker_sentiment_label": "Neutral"}]}, {"title": "Why Shift Technologies Shares Are Trading Lower By 15%; Here Are 20 Stocks Moving Premarket - Ault Alliance  ( AMEX:AULT ) , Arcturus Therapeutics  ( NASDAQ:ARCT ) ", "url": "https://www.benzinga.com/news/23/03/31545940/why-shift-technologies-shares-are-trading-lower-by-15-here-are-20-stocks-moving-premarket", "time_published": "20230329T120556", "authors": ["Lisa Levin"], "summary": "LogicMark, Inc. LGMK shares rose 36.7% to $0.1914 in pre-market trading after the company reported strong revenue and margin growth for the year ended 2022. Biodexa Pharmaceuticals Plc BDRX gained 36.3% to $0.6758 in pre-market trading. Biodexa Pharmaceuticals reported exercise of warrants and ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/29/shift_technologies_-_logo.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.2"}, {"topic": "Financial Markets", "relevance_score": "0.82617"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.875462"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": 0.104323, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BRDS", "relevance_score": "0.154455", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFT", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.039368", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.229872", "ticker_sentiment_score": "-0.007244", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICCM", "relevance_score": "0.229872", "ticker_sentiment_score": "0.285397", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DPRO", "relevance_score": "0.229872", "ticker_sentiment_score": "0.149427", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBX", "relevance_score": "0.229872", "ticker_sentiment_score": "0.010946", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIFR", "relevance_score": "0.154455", "ticker_sentiment_score": "0.316293", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LULU", "relevance_score": "0.154455", "ticker_sentiment_score": "0.441069", "ticker_sentiment_label": "Bullish"}, {"ticker": "OCG", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.08665", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.336601", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "STAR", "relevance_score": "0.077593", "ticker_sentiment_score": "0.092172", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.229872", "ticker_sentiment_score": "0.155912", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NABL", "relevance_score": "0.229872", "ticker_sentiment_score": "0.156741", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "LGMK", "relevance_score": "0.154455", "ticker_sentiment_score": "0.358054", "ticker_sentiment_label": "Bullish"}, {"ticker": "ARCT", "relevance_score": "0.154455", "ticker_sentiment_score": "0.279237", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HLBZ", "relevance_score": "0.229872", "ticker_sentiment_score": "0.197788", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MINM", "relevance_score": "0.154455", "ticker_sentiment_score": "-0.276671", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "US Stocks Open Higher; Dow Rises 200 Points - First Citizens BancShares  ( NASDAQ:FCNCA ) , First Republic Bank  ( NYSE:FRC ) ", "url": "https://www.benzinga.com/news/earnings/23/03/31512485/us-stocks-open-higher-dow-rises-200-points", "time_published": "20230327T135653", "authors": ["Lisa Levin"], "summary": "U.S. stocks traded higher this morning, with the Dow Jones gaining around 200 points on Monday. Following the market opening Monday, the Dow traded up 0.64% to 32,443.64 while the NASDAQ rose 0.20% to 11,848.04. The S&P 500, also rose, gaining, 0.52% to 3,991.63. Financials shares jumped by 1.8% ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/27/image20.jpg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.108179"}, {"topic": "Technology", "relevance_score": "0.333333"}, {"topic": "Finance", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.144186, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "GOOG", "relevance_score": "0.061315", "ticker_sentiment_score": "-0.084005", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.182506", "ticker_sentiment_score": "0.277951", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FYBR", "relevance_score": "0.122269", "ticker_sentiment_score": "-0.095795", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRC", "relevance_score": "0.182506", "ticker_sentiment_score": "0.346663", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "MS", "relevance_score": "0.061315", "ticker_sentiment_score": "-0.084005", "ticker_sentiment_label": "Neutral"}, {"ticker": "CZBS", "relevance_score": "0.182506", "ticker_sentiment_score": "0.340672", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FIZN", "relevance_score": "0.182506", "ticker_sentiment_score": "0.340672", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "UBX", "relevance_score": "0.122269", "ticker_sentiment_score": "0.197048", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CRYPTO:ETH", "relevance_score": "0.061315", "ticker_sentiment_score": "-0.179528", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:AGI", "relevance_score": "0.061315", "ticker_sentiment_score": "-0.179528", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Why GameStop Shares Are Trading Higher By Around 44%; Here Are 20 Stocks Moving Premarket - Blue Water Vaccines  ( NASDAQ:BWV ) , Cerberus Cyber Sentinel  ( NASDAQ:CISO ) ", "url": "https://www.benzinga.com/news/23/03/31454414/why-gamestop-shares-are-trading-higher-by-around-44-here-are-20-stocks-moving-premarket", "time_published": "20230322T120720", "authors": ["Lisa Levin"], "summary": "Virgin Orbit Holdings, Inc. VORB shares rose 81.2% to $0.8032 in pre-market trading. Richard Branson's Virgin Orbit is nearing a deal for a $200 million investment from Texas-based Venture Capital investor Matthew Brown via a private share placement, according to a term sheet. GameStop Corp.", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/22/image30.jpeg?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.25"}, {"topic": "Technology", "relevance_score": "0.25"}, {"topic": "Blockchain", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.25"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Real Estate & Construction", "relevance_score": "0.25"}], "overall_sentiment_score": 0.113132, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "BWV", "relevance_score": "0.217508", "ticker_sentiment_score": "0.477413", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.146025", "ticker_sentiment_score": "0.0", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.217508", "ticker_sentiment_score": "0.174702", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "CXAI", "relevance_score": "0.146025", "ticker_sentiment_score": "0.170162", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PEAR", "relevance_score": "0.217508", "ticker_sentiment_score": "-0.200889", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DBD", "relevance_score": "0.217508", "ticker_sentiment_score": "0.218813", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "JMAC", "relevance_score": "0.146025", "ticker_sentiment_score": "0.170162", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "QLGN", "relevance_score": "0.217508", "ticker_sentiment_score": "0.269804", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NVOS", "relevance_score": "0.146025", "ticker_sentiment_score": "-0.016539", "ticker_sentiment_label": "Neutral"}, {"ticker": "LXEH", "relevance_score": "0.146025", "ticker_sentiment_score": "0.209095", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "NCNA", "relevance_score": "0.146025", "ticker_sentiment_score": "-0.220383", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GLS", "relevance_score": "0.146025", "ticker_sentiment_score": "-0.393555", "ticker_sentiment_label": "Bearish"}, {"ticker": "QTT", "relevance_score": "0.217508", "ticker_sentiment_score": "0.159643", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "WAVD", "relevance_score": "0.217508", "ticker_sentiment_score": "0.052097", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBIO", "relevance_score": "0.146025", "ticker_sentiment_score": "0.423682", "ticker_sentiment_label": "Bullish"}, {"ticker": "HPCO", "relevance_score": "0.146025", "ticker_sentiment_score": "-0.23542", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "KAL", "relevance_score": "0.146025", "ticker_sentiment_score": "0.028527", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISO", "relevance_score": "0.217508", "ticker_sentiment_score": "0.068387", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.146025", "ticker_sentiment_score": "0.264175", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "$5M Bet On Pyxis Oncology? Check Out These 4 Penny Stocks Insiders Are Buying - Bird Glb  ( NYSE:BRDS ) , Champions Oncology  ( NASDAQ:CSBR ) ", "url": "https://www.benzinga.com/trading-ideas/long-ideas/23/03/31453546/5m-bet-on-pyxis-oncology-check-out-these-4-penny-stocks-insiders-are-buying", "time_published": "20230322T112113", "authors": ["Lisa Levin"], "summary": "The Dow Jones closed higher by more than 300 points on Tuesday. When insiders purchase or sell shares, it indicates their confidence or concern around the company's prospects. Investors and traders interested in penny stocks can consider this a factor in their overall investment or trading ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2023/03/22/image21.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.333333"}, {"topic": "Financial Markets", "relevance_score": "0.161647"}, {"topic": "Manufacturing", "relevance_score": "0.333333"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.214378"}, {"topic": "Technology", "relevance_score": "0.333333"}], "overall_sentiment_score": 0.324162, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "BRDS", "relevance_score": "0.454714", "ticker_sentiment_score": "0.554066", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.454714", "ticker_sentiment_score": "0.436049", "ticker_sentiment_label": "Bullish"}, {"ticker": "PFE", "relevance_score": "0.096283", "ticker_sentiment_score": "0.13807", "ticker_sentiment_label": "Neutral"}, {"ticker": "CSBR", "relevance_score": "0.454714", "ticker_sentiment_score": "0.344482", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "TOI", "relevance_score": "0.454714", "ticker_sentiment_score": "0.410948", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pyxis Oncology Reports Financial Results for the Fiscal Year Ended December 31, 2022, and Provides Corporate Update", "url": "https://www.globenewswire.com/news-release/2023/03/22/2632035/0/en/Pyxis-Oncology-Reports-Financial-Results-for-the-Fiscal-Year-Ended-December-31-2022-and-Provides-Corporate-Update.html", "time_published": "20230322T104500", "authors": ["Pyxis Oncology"], "summary": "Preliminary data from two Phase 1 trials anticipated late 2023 to early ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.158519"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.123042, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.233877", "ticker_sentiment_score": "0.144728", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Dosing of First Subject in Phase 1 Trial of PYX-201, a Novel ADC for Solid Tumors", "url": "https://www.globenewswire.com/news-release/2023/03/16/2628535/0/en/Pyxis-Oncology-Announces-Dosing-of-First-Subject-in-Phase-1-Trial-of-PYX-201-a-Novel-ADC-for-Solid-Tumors.html", "time_published": "20230316T113000", "authors": ["Pyxis Oncology"], "summary": "Milestone marks transition of Pyxis Oncology to a clinical-stage company ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": -0.012204, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.256314", "ticker_sentiment_score": "0.022122", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.06515", "ticker_sentiment_score": "0.160302", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology to Participate in the Virtual 2023 SVB Securities Global Biopharma Conference", "url": "https://www.globenewswire.com/news-release/2023/02/13/2606558/0/en/Pyxis-Oncology-to-Participate-in-the-Virtual-2023-SVB-Securities-Global-Biopharma-Conference.html", "time_published": "20230213T130000", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., Feb. 13, 2023 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, Pamela ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.451494"}], "overall_sentiment_score": -0.012008, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.265378", "ticker_sentiment_score": "0.077689", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2022/12/23/2579265/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20221223T214500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., Dec. 23, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a clinical stage company focused on developing next-generation therapeutics to target difficult-to-treat cancers, reported on December 23, 2022 that Pyxis Oncology's Compensation Committee of the Board ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.100886, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.63188", "ticker_sentiment_score": "0.210573", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology Announces FDA Clearance of Two IND Applications", "url": "https://www.globenewswire.com/news-release/2022/12/01/2565733/0/en/Pyxis-Oncology-Announces-FDA-Clearance-of-Two-IND-Applications.html", "time_published": "20221201T114500", "authors": ["Pyxis Oncology"], "summary": "FDA grants IND clearances of PYX-201, a novel antibody-drug conjugate ( ADC ) product candidate, and PYX-106, an immunotherapy product candidate ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.079301, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.188193", "ticker_sentiment_score": "0.057492", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.031654", "ticker_sentiment_score": "0.092079", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2022/09/30/2526351/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20220930T210000", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., Sept. 30, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a diversified oncology company focused on developing an arsenal of next-generation therapeutics to target difficult-to-treat cancers and improve quality of life for patients, reported on September 30, ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.140324, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.108466", "ticker_sentiment_score": "0.004586", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.724687", "ticker_sentiment_score": "0.291636", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Chops Development On Preclinical Assets", "url": "https://www.benzinga.com/general/biotech/22/08/28499217/pyxis-chops-development-on-preclinical-assets", "time_published": "20220815T171959", "authors": ["Vandana Singh"], "summary": "Pyxis Oncology Inc PYXS is shifting its short-term emphasis to focus on two programs. \"We have elected to sharpen our near-term focus on the clinical execution of our two most advanced programs, anti-EDB Antibody Drug Conjugate ( ADC ) , PYX-201, and anti-Siglec-15 monoclonal antibody ( mAb ) , ...", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/08/15/aapharma_14.png?optimize=medium&dpr=2&auto=webp&width=3840", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.146128, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.252114", "ticker_sentiment_score": "0.131794", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Financial Results for the Second Quarter Ended June 30, 2022 and Provides Pipeline Update", "url": "https://www.globenewswire.com/news-release/2022/08/15/2498065/0/en/Pyxis-Oncology-Reports-Financial-Results-for-the-Second-Quarter-Ended-June-30-2022-and-Provides-Pipeline-Update.html", "time_published": "20220815T110000", "authors": ["Pyxis Oncology"], "summary": "\u2022 Prioritized pipeline to focus on most advanced programs while maintaining financial flexibility to pursue business development opportunities ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.77141"}, {"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Mergers & Acquisitions", "relevance_score": "0.158519"}, {"topic": "Technology", "relevance_score": "0.5"}], "overall_sentiment_score": 0.137052, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.024597", "ticker_sentiment_score": "0.003808", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.356268", "ticker_sentiment_score": "0.193997", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "BDIMF", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDTX", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.024597", "ticker_sentiment_score": "-0.011764", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635 ( c )  ( 4 ) ", "url": "https://www.globenewswire.com/news-release/2022/07/12/2477876/0/en/Pyxis-Oncology-Reports-Inducement-Grants-Under-Nasdaq-Listing-Rule-5635-c-4.html", "time_published": "20220712T104500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., July 12, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , an oncology company focused on developing next-generation therapeutics for difficult-to-treat cancers, reported on July 1, 2022 that Pyxis Oncology's Board of Directors granted restricted stock units ...", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.99393"}], "overall_sentiment_score": 0.105988, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.117486", "ticker_sentiment_score": "0.008539", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.816498", "ticker_sentiment_score": "0.178547", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference", "url": "https://www.globenewswire.com/news-release/2022/06/28/2470170/0/en/Pyxis-Oncology-to-Present-at-H-C-Wainwright-Preclinical-Cancer-Drug-Discovery-Conference.html", "time_published": "20220628T103500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., June 28, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , an oncology company focused on developing next-generation therapeutics for difficult-to-treat cancers, today announced that the Company will present at the H.C.", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.077574, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.150404", "ticker_sentiment_score": "0.139928", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.744796", "ticker_sentiment_score": "0.077574", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Present at H.C. Wainwright Preclinical Cancer Drug Discovery Conference", "url": "https://www.benzinga.com/pressreleases/22/06/g27877377/pyxis-oncology-to-present-at-h-c-wainwright-preclinical-cancer-drug-discovery-conference", "time_published": "20220628T103500", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., June 28, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. PYXS, an oncology company focused on developing next-generation therapeutics for difficult-to-treat cancers, today announced that the Company will present at the H.C.", "banner_image": "", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.059376, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.126985", "ticker_sentiment_score": "0.148558", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.736777", "ticker_sentiment_score": "0.077032", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Presentations at Upcoming Investor Conferences", "url": "https://www.globenewswire.com/news-release/2022/05/19/2446722/0/en/Pyxis-Oncology-Announces-Presentations-at-Upcoming-Investor-Conferences.html", "time_published": "20220519T103500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., May 19, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, a", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.089893, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.163243", "ticker_sentiment_score": "0.148916", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.783639", "ticker_sentiment_score": "0.089893", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Presentations at Upcoming Investor Conferences", "url": "https://www.benzinga.com/pressreleases/22/05/g27296022/pyxis-oncology-announces-presentations-at-upcoming-investor-conferences", "time_published": "20220519T103500", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., May 19, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( NASDAQ:PYXS ) , a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, an", "banner_image": "https://ml.globenewswire.com/media/dc89ff40-4e91-444f-9ffd-3d68093dc029/small/full-color-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.043212, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.135959", "ticker_sentiment_score": "0.112749", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.769328", "ticker_sentiment_score": "0.063318", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/markets/options/22/05/27226401/52-weeks-high-and-low-article", "time_published": "20220516T175917", "authors": ["Benzinga Insights"], "summary": "On Monday, 198 companies reached new 52-week lows. Noteworthy Mentions In Today's 52-Week Lows: BlackRock ( NYSE:BLK ) was the largest firm by market cap to set a new 52-week low. The smallest company by market cap to set a new 52-week low was Vallon Pharmaceuticals ( NASDAQ:VLON ) . Chimerix (", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8697.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.023675, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "AHI", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.003672", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.009321", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVEX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006389", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNC", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000549", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.009344", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTRX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.300091", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JOAN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.168708", "ticker_sentiment_score": "-0.006268", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.003474", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006898", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBY", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.005872", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRMD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.249573", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OCCI", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001154", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENT", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBMT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.022374", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00973", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.026147", "ticker_sentiment_score": "0.012978", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMRX", "relevance_score": "0.039212", "ticker_sentiment_score": "-0.006743", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.09217", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.026147", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOFT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.002781", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOND", "relevance_score": "0.026147", "ticker_sentiment_score": "0.020603", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.026147", "ticker_sentiment_score": "0.088231", "ticker_sentiment_label": "Neutral"}, {"ticker": "XGN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007233", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.168708", "ticker_sentiment_score": "0.006205", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.006187", "ticker_sentiment_label": "Neutral"}, {"ticker": "POAI", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.015639", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUMA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.011926", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002725", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.026147", "ticker_sentiment_score": "0.005169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.000679", "ticker_sentiment_label": "Neutral"}, {"ticker": "BSRR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBNC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.008161", "ticker_sentiment_label": "Neutral"}, {"ticker": "GCMG", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002198", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000763", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNUN", "relevance_score": "0.013075", "ticker_sentiment_score": "0.009538", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRGA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010208", "ticker_sentiment_label": "Neutral"}, {"ticker": "URGN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.023251", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.035222", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.013076", "ticker_sentiment_label": "Neutral"}, {"ticker": "OVID", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.018354", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASNS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.012814", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007176", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTXAP", "relevance_score": "0.013075", "ticker_sentiment_score": "0.009734", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.002345", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001397", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.007947", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETN", "relevance_score": "0.039212", "ticker_sentiment_score": "-0.001009", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVCO", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.110115", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.041244", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010704", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCOM", "relevance_score": "0.026147", "ticker_sentiment_score": "0.009538", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSWL", "relevance_score": "0.026147", "ticker_sentiment_score": "0.027174", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001853", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRMR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.082926", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001819", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.010607", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.006686", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADV", "relevance_score": "0.026147", "ticker_sentiment_score": "0.026697", "ticker_sentiment_label": "Neutral"}, {"ticker": "TALS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.01369", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUVL", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.239551", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FORD", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004667", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCCO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.012123", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000196", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.22125", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HTLF", "relevance_score": "0.026147", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EQ", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.015689", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCSG", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.22125", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IREN", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.003521", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000826", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBAY", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.000183", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTTA", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.174483", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FFWM", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00194", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.016929", "ticker_sentiment_label": "Neutral"}, {"ticker": "WASH", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004425", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.026147", "ticker_sentiment_score": "0.0051", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.005621", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.035642", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.170933", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "UMPQ", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004235", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPH", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.009103", "ticker_sentiment_label": "Neutral"}, {"ticker": "OZK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.002554", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSBW", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.021729", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBCP", "relevance_score": "0.026147", "ticker_sentiment_score": "0.007982", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.026147", "ticker_sentiment_score": "0.000709", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.078328", "ticker_sentiment_score": "0.005893", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004499", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFST", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.00093", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVLO", "relevance_score": "0.026147", "ticker_sentiment_score": "0.001081", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.252577", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RYB", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.231046", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HRTG", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.011215", "ticker_sentiment_label": "Neutral"}, {"ticker": "USWS", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.043356", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.026147", "ticker_sentiment_score": "0.01074", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKH", "relevance_score": "0.013075", "ticker_sentiment_score": "0.013076", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.013075", "ticker_sentiment_score": "0.012978", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFBC", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.001377", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBNK", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.004487", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATBP", "relevance_score": "0.013075", "ticker_sentiment_score": "-0.007585", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPB", "relevance_score": "0.026147", "ticker_sentiment_score": "0.00221", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.026147", "ticker_sentiment_score": "0.005918", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.026147", "ticker_sentiment_score": "-0.013781", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Reports Financial Results for the Quarter Ended March 31, 2022 and Provides Business Update", "url": "https://www.globenewswire.com/news-release/2022/05/13/2442993/0/en/Pyxis-Oncology-Reports-Financial-Results-for-the-Quarter-Ended-March-31-2022-and-Provides-Business-Update.html", "time_published": "20220513T120300", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., May 13, 2022 ( GLOBE NEWSWIRE ) -- Pyxis Oncology, Inc. ( Nasdaq: PYXS ) , a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today reported financial results for its first quarter ended March 31, 2022. The C", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.744043"}], "overall_sentiment_score": 0.030106, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.043826", "ticker_sentiment_score": "0.14774", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.339803", "ticker_sentiment_score": "0.055195", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Wednesday", "url": "https://www.benzinga.com/markets/options/22/05/27141482/52-weeks-high-and-low-article", "time_published": "20220511T162815", "authors": ["Benzinga Insights"], "summary": "On Wednesday, 807 companies reached new 52-week lows.\nThings to Consider About Today's 52-Week Lows:\nAmazon.com  ( NASDAQ:AMZN )  was the largest company by market cap to set a new 52-week low.\nGames & Esports  ( NASDAQ:GEEXW )  was the smallest company by market cap to set a new 52-week low.\nView  ", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_8443.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Blockchain", "relevance_score": "0.451494"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.026939, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "FLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010843", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00124", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.036124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRIP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006292", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003313", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHYF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000149", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002042", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005129", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000991", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVID", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005953", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRSX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTAIF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.370079", "ticker_sentiment_label": "Bearish"}, {"ticker": "SCOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053563", "ticker_sentiment_label": "Neutral"}, {"ticker": "PASG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007315", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008312", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004985", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.006905", "ticker_sentiment_score": "0.046669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006647", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMED", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028036", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOTV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0346", "ticker_sentiment_label": "Neutral"}, {"ticker": "HESG", "relevance_score": "0.006905", "ticker_sentiment_score": "8.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001386", "ticker_sentiment_label": "Neutral"}, {"ticker": "WMG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.435265", "ticker_sentiment_label": "Bearish"}, {"ticker": "AZRE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007661", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010696", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000104", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.569147", "ticker_sentiment_label": "Bearish"}, {"ticker": "VITL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01899", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009834", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTOO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002672", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXON", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006481", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023031", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "HROW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00396", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABCL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTCY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000956", "ticker_sentiment_label": "Neutral"}, {"ticker": "W", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.030942", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADGI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006892", "ticker_sentiment_label": "Neutral"}, {"ticker": "EOSE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006208", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027974", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTER", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001811", "ticker_sentiment_label": "Neutral"}, {"ticker": "JZXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004785", "ticker_sentiment_label": "Neutral"}, {"ticker": "UGRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003781", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000185", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001624", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033286", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.032128", "ticker_sentiment_label": "Neutral"}, {"ticker": "CKPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007747", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014035", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.026043", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002584", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030553", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005663", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMZN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.102966", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATIP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.018006", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010726", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUEN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.083313", "ticker_sentiment_label": "Neutral"}, {"ticker": "DH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002316", "ticker_sentiment_label": "Neutral"}, {"ticker": "JNCE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01368", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKTW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001209", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.114162", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001387", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002708", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.041261", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000686", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001014", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-5.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029453", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.503669", "ticker_sentiment_label": "Bearish"}, {"ticker": "ABEO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010621", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001583", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARDS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.044931", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLSK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057114", "ticker_sentiment_label": "Neutral"}, {"ticker": "TJX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025648", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLPN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.442405", "ticker_sentiment_label": "Bearish"}, {"ticker": "LEJU", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "PBYI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007044", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013268", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNGX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.027942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VXRT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00338", "ticker_sentiment_label": "Neutral"}, {"ticker": "YUM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.028553", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLDB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010371", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFMD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002608", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONTF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033985", "ticker_sentiment_label": "Neutral"}, {"ticker": "VOR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "AADI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008683", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEJO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001147", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISPC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.029975", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00083", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001639", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031721", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACIU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006969", "ticker_sentiment_label": "Neutral"}, {"ticker": "DLX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005509", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRWG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007522", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003138", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIDE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002347", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.026602", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAYO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006817", "ticker_sentiment_label": "Neutral"}, {"ticker": "BITF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000946", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003622", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLTX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001759", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002882", "ticker_sentiment_label": "Neutral"}, {"ticker": "APDN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01973", "ticker_sentiment_label": "Neutral"}, {"ticker": "GP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELOX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007027", "ticker_sentiment_label": "Neutral"}, {"ticker": "WULF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCID", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001298", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002991", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015008", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLVS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006371", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000529", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVCM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002414", "ticker_sentiment_label": "Neutral"}, {"ticker": "HD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004448", "ticker_sentiment_label": "Neutral"}, {"ticker": "AHG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003716", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005806", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006652", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSWA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032353", "ticker_sentiment_label": "Neutral"}, {"ticker": "APEI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.274715", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "VERI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009191", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.006905", "ticker_sentiment_score": "-7.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NABL", "relevance_score": "0.01381", "ticker_sentiment_score": "-0.065212", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHAK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016476", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.035094", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.017236", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "MPAA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004494", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWFL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005494", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006302", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.027744", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVRO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019477", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.380308", "ticker_sentiment_label": "Bearish"}, {"ticker": "YTEN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020472", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMGO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03797", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.199176", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SBTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008026", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00697", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.284624", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SMP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.027647", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.033445", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004023", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010277", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPZM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009908", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRCT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.020713", "ticker_sentiment_score": "-0.00707", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KALV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001403", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004038", "ticker_sentiment_label": "Neutral"}, {"ticker": "VALN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029958", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.053345", "ticker_sentiment_label": "Neutral"}, {"ticker": "RKLB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.395079", "ticker_sentiment_label": "Bearish"}, {"ticker": "IONQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000885", "ticker_sentiment_label": "Neutral"}, {"ticker": "SZCRF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.01049", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.057804", "ticker_sentiment_label": "Neutral"}, {"ticker": "CFMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.057018", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013737", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002159", "ticker_sentiment_label": "Neutral"}, {"ticker": "KD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000517", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKIL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00385", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004625", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAMOD", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.011888", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.201653", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014804", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBTYA", "relevance_score": "0.01381", "ticker_sentiment_score": "0.000537", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.034535", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOPA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002931", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009368", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00339", "ticker_sentiment_label": "Neutral"}, {"ticker": "WWW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014879", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00256", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005779", "ticker_sentiment_label": "Neutral"}, {"ticker": "CVNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02828", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNRC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008229", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDXX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009155", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04243", "ticker_sentiment_label": "Neutral"}, {"ticker": "KTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.358226", "ticker_sentiment_label": "Bearish"}, {"ticker": "TARA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00569", "ticker_sentiment_label": "Neutral"}, {"ticker": "LL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006707", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.03686", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.360118", "ticker_sentiment_label": "Bearish"}, {"ticker": "LAW", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00929", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003194", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.023385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MODN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020967", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014444", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABNB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004281", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004349", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002269", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00821", "ticker_sentiment_label": "Neutral"}, {"ticker": "DSGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000891", "ticker_sentiment_label": "Neutral"}, {"ticker": "MC", "relevance_score": "0.006905", "ticker_sentiment_score": "-3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ME", "relevance_score": "0.003453", "ticker_sentiment_score": "0.131467", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLNE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005482", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029909", "ticker_sentiment_label": "Neutral"}, {"ticker": "NXTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020147", "ticker_sentiment_label": "Neutral"}, {"ticker": "ML", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005557", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003453", "ticker_sentiment_score": "0.008905", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016002", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392024", "ticker_sentiment_label": "Bearish"}, {"ticker": "SMMT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010153", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLUG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011101", "ticker_sentiment_label": "Neutral"}, {"ticker": "LESL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000751", "ticker_sentiment_label": "Neutral"}, {"ticker": "DTC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019578", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNWD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015302", "ticker_sentiment_label": "Neutral"}, {"ticker": "REAL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.01087", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003034", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MIXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007657", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006713", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKLZ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.018388", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003455", "ticker_sentiment_label": "Neutral"}, {"ticker": "VAPO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004429", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.066657", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKAN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009858", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANY", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001463", "ticker_sentiment_label": "Neutral"}, {"ticker": "INPX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003723", "ticker_sentiment_label": "Neutral"}, {"ticker": "MFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012664", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.219042", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AEVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009159", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.011478", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031329", "ticker_sentiment_label": "Neutral"}, {"ticker": "OB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001471", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRIX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003443", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001551", "ticker_sentiment_label": "Neutral"}, {"ticker": "OM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DUO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.03401", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMFA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021611", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNUS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033908", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02022", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIHO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005958", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEOG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004778", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRPX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.042368", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006722", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006844", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005504", "ticker_sentiment_label": "Neutral"}, {"ticker": "APG", "relevance_score": "0.003453", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUVI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.019138", "ticker_sentiment_label": "Neutral"}, {"ticker": "API", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003362", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012249", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNFT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007461", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTOS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004453", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001344", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001857", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007561", "ticker_sentiment_label": "Neutral"}, {"ticker": "EYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012451", "ticker_sentiment_label": "Neutral"}, {"ticker": "JBI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00277", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.006905", "ticker_sentiment_score": "4.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NCNO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013924", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01167", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLUE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004193", "ticker_sentiment_label": "Neutral"}, {"ticker": "PNR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000195", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTIX", "relevance_score": "0.006905", "ticker_sentiment_score": "5.2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EFOI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.029837", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009979", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004065", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNXT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.013037", "ticker_sentiment_label": "Neutral"}, {"ticker": "CODX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEAT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010594", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.020369", "ticker_sentiment_label": "Neutral"}, {"ticker": "ILMN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02254", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSFE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014456", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.066369", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017007", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.003453", "ticker_sentiment_score": "0.006269", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.031576", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNGO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02275", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEYE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012576", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002829", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRDS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.354538", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00193", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.259224", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "MIR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004637", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.074059", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004011", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.024874", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOPN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001667", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.015082", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012462", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005954", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003477", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HIMS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009111", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMCO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005184", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00475", "ticker_sentiment_label": "Neutral"}, {"ticker": "IXHL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.020635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000674", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACVA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002797", "ticker_sentiment_label": "Neutral"}, {"ticker": "NLS", "relevance_score": "0.010357", "ticker_sentiment_score": "0.001464", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCRX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "DYN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010556", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000724", "ticker_sentiment_label": "Neutral"}, {"ticker": "KGC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.012165", "ticker_sentiment_label": "Neutral"}, {"ticker": "QSI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004396", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004931", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001103", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNFR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019067", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001252", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000834", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003095", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003971", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001533", "ticker_sentiment_label": "Neutral"}, {"ticker": "NNDM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RIOT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02771", "ticker_sentiment_label": "Neutral"}, {"ticker": "WOLF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.083853", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSTR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VORB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALIT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.031917", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPWK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.041747", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEPG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007504", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEV", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007498", "ticker_sentiment_label": "Neutral"}, {"ticker": "UA", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.029087", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011377", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDHL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.298818", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PZZA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001777", "ticker_sentiment_label": "Neutral"}, {"ticker": "TFFP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009522", "ticker_sentiment_label": "Neutral"}, {"ticker": "UP", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.004382", "ticker_sentiment_label": "Neutral"}, {"ticker": "VCYT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00325", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0191", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001282", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWIM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004749", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001507", "ticker_sentiment_label": "Neutral"}, {"ticker": "LASR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008075", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARVL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009289", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMVT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.392113", "ticker_sentiment_label": "Bearish"}, {"ticker": "FBIO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002737", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025009", "ticker_sentiment_label": "Neutral"}, {"ticker": "PWUP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.028695", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVTL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.016997", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.039738", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTGC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011907", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPAY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009098", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AWH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001674", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002578", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000342", "ticker_sentiment_label": "Neutral"}, {"ticker": "MITSF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "TNXP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021993", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHSI", "relevance_score": "0.006905", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYEL", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTPI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007203", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPTH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.362989", "ticker_sentiment_label": "Bearish"}, {"ticker": "NCTY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006714", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010066", "ticker_sentiment_label": "Neutral"}, {"ticker": "WW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.014569", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.010513", "ticker_sentiment_label": "Neutral"}, {"ticker": "OUST", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.294166", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ORMP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000939", "ticker_sentiment_label": "Neutral"}, {"ticker": "KZIA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007505", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.374918", "ticker_sentiment_label": "Bearish"}, {"ticker": "SFIX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000996", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIDR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "STEP", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.045373", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017264", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004172", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.001723", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLIN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.008014", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTIM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.285345", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "HYPR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003699", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUWE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001889", "ticker_sentiment_label": "Neutral"}, {"ticker": "OST", "relevance_score": "0.006905", "ticker_sentiment_score": "0.0003", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "XL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.04092", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEWR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012623", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSUMF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.00541", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.002248", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010603", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.021702", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.02631", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006837", "ticker_sentiment_label": "Neutral"}, {"ticker": "FNCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001556", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTNT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.0152", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009431", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007666", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.002913", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTRA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005884", "ticker_sentiment_label": "Neutral"}, {"ticker": "HITI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.059974", "ticker_sentiment_label": "Neutral"}, {"ticker": "PETQ", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004692", "ticker_sentiment_label": "Neutral"}, {"ticker": "IRBT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007552", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVPH", "relevance_score": "0.006905", "ticker_sentiment_score": "3.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000267", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.30025", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "TNYA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.021404", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.011834", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007334", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005064", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCTH", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010679", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.280779", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FVRR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000429", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003156", "ticker_sentiment_label": "Neutral"}, {"ticker": "LHDX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.332594", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ELAN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005139", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007599", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPL", "relevance_score": "0.006905", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "RYLPF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.303151", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "EAR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.515459", "ticker_sentiment_label": "Bearish"}, {"ticker": "ZS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMPG", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002864", "ticker_sentiment_label": "Neutral"}, {"ticker": "RRGB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004799", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLKB", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003166", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.038783", "ticker_sentiment_label": "Neutral"}, {"ticker": "HHC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002274", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYCC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003547", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.032123", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009183", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBS", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00365", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIRX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003406", "ticker_sentiment_label": "Neutral"}, {"ticker": "KOD", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.044645", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRZE", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019028", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGG", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009685", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGFS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKKT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010394", "ticker_sentiment_label": "Neutral"}, {"ticker": "CIDM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004099", "ticker_sentiment_label": "Neutral"}, {"ticker": "MORF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012244", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.033794", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017902", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019061", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMRN", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004583", "ticker_sentiment_label": "Neutral"}, {"ticker": "MXCT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008606", "ticker_sentiment_label": "Neutral"}, {"ticker": "TELA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICHR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019517", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADAP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009332", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUNW", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.015065", "ticker_sentiment_label": "Neutral"}, {"ticker": "URBN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.185111", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "APYX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00253", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003239", "ticker_sentiment_label": "Neutral"}, {"ticker": "POLA", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004544", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.473604", "ticker_sentiment_label": "Bearish"}, {"ticker": "BRSYF", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.009217", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.006905", "ticker_sentiment_score": "0.065524", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003907", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNSO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.003669", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.010652", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.006905", "ticker_sentiment_score": "0.016657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005464", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNCA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004492", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006496", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMAB", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006537", "ticker_sentiment_label": "Neutral"}, {"ticker": "CORZ", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005167", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRTS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002222", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEAM", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.012732", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009064", "ticker_sentiment_label": "Neutral"}, {"ticker": "KYMR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009894", "ticker_sentiment_label": "Neutral"}, {"ticker": "SI-P-A", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.017179", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIBS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.025121", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAUT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "WEBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.019209", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIND", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.542631", "ticker_sentiment_label": "Bearish"}, {"ticker": "GOEV", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006919", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLNK", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.006117", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.46795", "ticker_sentiment_label": "Bearish"}, {"ticker": "TACT", "relevance_score": "0.006905", "ticker_sentiment_score": "0.00013", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.005671", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGPPF", "relevance_score": "0.003453", "ticker_sentiment_score": "0.001751", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.303128", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HLF", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.030714", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIT", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.01328", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCS", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.009974", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRAR", "relevance_score": "0.006905", "ticker_sentiment_score": "0.062454", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.006905", "ticker_sentiment_score": "0.000832", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCX", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.001263", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLBE", "relevance_score": "0.006905", "ticker_sentiment_score": "0.006434", "ticker_sentiment_label": "Neutral"}, {"ticker": "INO", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTCH", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.017918", "ticker_sentiment_label": "Neutral"}, {"ticker": "VHC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007314", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLAY", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.002596", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKLA", "relevance_score": "0.006905", "ticker_sentiment_score": "0.086181", "ticker_sentiment_label": "Neutral"}, {"ticker": "COSM", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003579", "ticker_sentiment_label": "Neutral"}, {"ticker": "CWBR", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.005085", "ticker_sentiment_label": "Neutral"}, {"ticker": "HURC", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.007955", "ticker_sentiment_label": "Neutral"}, {"ticker": "UBER", "relevance_score": "0.006905", "ticker_sentiment_score": "0.025491", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMC", "relevance_score": "0.006905", "ticker_sentiment_score": "0.004826", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSTX", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009901", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.008017", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOXD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.001828", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.004273", "ticker_sentiment_label": "Neutral"}, {"ticker": "BAK", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003009", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.006905", "ticker_sentiment_score": "0.003203", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLNN", "relevance_score": "0.006905", "ticker_sentiment_score": "-0.079266", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCON", "relevance_score": "0.006905", "ticker_sentiment_score": "0.007781", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.05939", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRSO", "relevance_score": "0.006905", "ticker_sentiment_score": "0.009408", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.002124", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NMR", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.326686", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRYPTO:AMPL", "relevance_score": "0.003453", "ticker_sentiment_score": "0.040609", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:BTX", "relevance_score": "0.003453", "ticker_sentiment_score": "0.00696", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:EOT", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.000625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:SLS", "relevance_score": "0.003453", "ticker_sentiment_score": "0.009625", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:TRX", "relevance_score": "0.003453", "ticker_sentiment_score": "-0.198959", "ticker_sentiment_label": "Somewhat-Bearish"}]}, {"title": "Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference", "url": "https://www.globenewswire.com/news-release/2022/04/27/2429991/0/en/Pyxis-Oncology-to-Participate-in-Fireside-Chat-at-BofA-Securities-2022-Healthcare-Conference.html", "time_published": "20220427T103500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., April  27, 2022   ( GLOBE NEWSWIRE )  -- Pyxis Oncology, Inc.  ( Nasdaq: PYXS ) , a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer,", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.158519"}], "overall_sentiment_score": 0.08572, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.160099", "ticker_sentiment_score": "0.148916", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.774534", "ticker_sentiment_score": "0.08572", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Participate in Fireside Chat at BofA Securities 2022 Healthcare Conference", "url": "https://www.benzinga.com/pressreleases/22/04/g26833162/pyxis-oncology-to-participate-in-fireside-chat-at-bofa-securities-2022-healthcare-conference", "time_published": "20220427T103500", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., April  27, 2022   ( GLOBE NEWSWIRE )  -- Pyxis Oncology, Inc.  ( NASDAQ:PYXS ) , a multi-asset multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced that Lara Sullivan, M.D., President and Chief Executive Officer, ", "banner_image": "https://ml.globenewswire.com/media/dc89ff40-4e91-444f-9ffd-3d68093dc029/small/full-color-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.360215"}], "overall_sentiment_score": 0.041676, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.135347", "ticker_sentiment_score": "0.112749", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.767202", "ticker_sentiment_score": "0.061037", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/markets/options/22/04/26742233/52-weeks-high-and-low-article", "time_published": "20220421T175401", "authors": ["Benzinga Insights"], "summary": "On Thursday, 236 companies hit new 52-week lows.\nIntriguing Points From Today's 52-Week Lows:\nSalesforce  ( NYSE:CRM )  was the largest firm by market cap to set a new 52-week low.\nVallon Pharmaceuticals  ( NASDAQ:VLON )  was the smallest firm by market cap to set a new 52-week low.\nAmpio Pharmaceut", "banner_image": "https://cdn.benzinga.com/files/images/story/2022/movers_image_7009.jpeg?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.021205, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "CABA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002381", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.087135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TWST", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006649", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENVX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00113", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01052", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.030051", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEN", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002758", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.022497", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001981", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERV", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009944", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYNE", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008619", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00781", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELYS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIXX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004795", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSNL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006897", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARRY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.300845", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HYRE", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007066", "ticker_sentiment_label": "Neutral"}, {"ticker": "JSPR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.014598", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00269", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOV", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00273", "ticker_sentiment_label": "Neutral"}, {"ticker": "IS", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.009612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009915", "ticker_sentiment_label": "Neutral"}, {"ticker": "EBET", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002463", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDEX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008528", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDF", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009832", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMER", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004491", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.029605", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007497", "ticker_sentiment_label": "Neutral"}, {"ticker": "WINT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006538", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.007612", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTXR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.020915", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATNF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.019945", "ticker_sentiment_label": "Neutral"}, {"ticker": "KERN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012905", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00033", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMEA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001906", "ticker_sentiment_label": "Neutral"}, {"ticker": "GENI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.106213", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001171", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.029072", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01144", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.275911", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PACK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.02721", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLON", "relevance_score": "0.043258", "ticker_sentiment_score": "-0.188735", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ZYME", "relevance_score": "0.021637", "ticker_sentiment_score": "0.127574", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.006918", "ticker_sentiment_label": "Neutral"}, {"ticker": "NBEV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.015053", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLUE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.008871", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003519", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.039881", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCYX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001819", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCUL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.000393", "ticker_sentiment_label": "Neutral"}, {"ticker": "OOMA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006997", "ticker_sentiment_label": "Neutral"}, {"ticker": "DJCO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004961", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003854", "ticker_sentiment_label": "Neutral"}, {"ticker": "TYRA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.016297", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.036058", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01678", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFCG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.281532", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BCRX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012726", "ticker_sentiment_label": "Neutral"}, {"ticker": "NMTR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006736", "ticker_sentiment_label": "Neutral"}, {"ticker": "Z", "relevance_score": "0.03245", "ticker_sentiment_score": "0.027112", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003807", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.305689", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "SEEL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00459", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006611", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMSC", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007523", "ticker_sentiment_label": "Neutral"}, {"ticker": "MCRB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010517", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.017051", "ticker_sentiment_label": "Neutral"}, {"ticker": "LBRDP", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009391", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000443", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRNE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003535", "ticker_sentiment_label": "Neutral"}, {"ticker": "DRRX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.078383", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005134", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETSY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008899", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00856", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.010485", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.226755", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GNRC", "relevance_score": "0.021637", "ticker_sentiment_score": "2e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00264", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUBO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004135", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002525", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.017299", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004381", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003188", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000793", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001875", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZNTL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.006916", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.419221", "ticker_sentiment_label": "Bearish"}, {"ticker": "GHG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.283903", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ALT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.28142", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BOLT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00614", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRTS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010254", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002313", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.0031", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.050277", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001072", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.007017", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010982", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTCI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.014516", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.010605", "ticker_sentiment_label": "Neutral"}, {"ticker": "ENJY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.014995", "ticker_sentiment_label": "Neutral"}, {"ticker": "NRXP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002158", "ticker_sentiment_label": "Neutral"}, {"ticker": "FORA", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.009674", "ticker_sentiment_label": "Neutral"}, {"ticker": "RBLX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000964", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005903", "ticker_sentiment_label": "Neutral"}, {"ticker": "EB", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.008842", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.000438", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002495", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTLA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004457", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.076352", "ticker_sentiment_label": "Neutral"}, {"ticker": "BWV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.052763", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005382", "ticker_sentiment_label": "Neutral"}, {"ticker": "FPAY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001576", "ticker_sentiment_label": "Neutral"}, {"ticker": "MGTA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.021511", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRON", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005956", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYTU", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002455", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNLI", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.270087", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "LCFY", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003964", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEM", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.004413", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.020588", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAFE", "relevance_score": "0.021637", "ticker_sentiment_score": "0.309149", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "DCT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.026108", "ticker_sentiment_label": "Neutral"}, {"ticker": "MYOV", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.035215", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.021637", "ticker_sentiment_score": "0.021999", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHLS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005212", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATRA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006966", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHTR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.004946", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.021637", "ticker_sentiment_score": "0.003813", "ticker_sentiment_label": "Neutral"}, {"ticker": "IEX", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.008528", "ticker_sentiment_label": "Neutral"}, {"ticker": "SQZ", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.001288", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRM", "relevance_score": "0.043258", "ticker_sentiment_score": "0.037599", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.003287", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.431235", "ticker_sentiment_label": "Bearish"}, {"ticker": "VAXX", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00036", "ticker_sentiment_label": "Neutral"}, {"ticker": "TTCF", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009887", "ticker_sentiment_label": "Neutral"}, {"ticker": "PGEN", "relevance_score": "0.021637", "ticker_sentiment_score": "0.010195", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.01106", "ticker_sentiment_label": "Neutral"}, {"ticker": "GSHD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00259", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.413847", "ticker_sentiment_label": "Bearish"}, {"ticker": "MRTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.018486", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.021637", "ticker_sentiment_score": "0.001187", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWTX", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002142", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGMO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00011", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHOP", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.012179", "ticker_sentiment_label": "Neutral"}, {"ticker": "HARP", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005109", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBD", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.011783", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLNC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.023889", "ticker_sentiment_label": "Neutral"}, {"ticker": "NSTG", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.436295", "ticker_sentiment_label": "Bearish"}, {"ticker": "VRAY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.0315", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLB", "relevance_score": "0.021637", "ticker_sentiment_score": "0.006139", "ticker_sentiment_label": "Neutral"}, {"ticker": "LUNA", "relevance_score": "0.021637", "ticker_sentiment_score": "0.007221", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRLD", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005525", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYPL", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.026772", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.021637", "ticker_sentiment_score": "0.001085", "ticker_sentiment_label": "Neutral"}, {"ticker": "LPRO", "relevance_score": "0.021637", "ticker_sentiment_score": "0.005236", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.043258", "ticker_sentiment_score": "0.22499", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "FNHC", "relevance_score": "0.021637", "ticker_sentiment_score": "0.013294", "ticker_sentiment_label": "Neutral"}, {"ticker": "RMBL", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002184", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTAI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.002113", "ticker_sentiment_label": "Neutral"}, {"ticker": "OYST", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000134", "ticker_sentiment_label": "Neutral"}, {"ticker": "WPRT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.002846", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.00702", "ticker_sentiment_label": "Neutral"}, {"ticker": "MMAT", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.024102", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKRO", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.306875", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FWBI", "relevance_score": "0.021637", "ticker_sentiment_score": "0.009235", "ticker_sentiment_label": "Neutral"}, {"ticker": "OCN", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.00507", "ticker_sentiment_label": "Neutral"}, {"ticker": "OTRK", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.358426", "ticker_sentiment_label": "Bearish"}, {"ticker": "RUBY", "relevance_score": "0.021637", "ticker_sentiment_score": "-0.029741", "ticker_sentiment_label": "Neutral"}, {"ticker": "FATBP", "relevance_score": "0.010819", "ticker_sentiment_score": "-0.00936", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.021637", "ticker_sentiment_score": "0.048038", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPID", "relevance_score": "0.021637", "ticker_sentiment_score": "0.000519", "ticker_sentiment_label": "Neutral"}]}, {"title": "68 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/04/26681653/68-biggest-movers-from-yesterday", "time_published": "20220419T083535", "authors": [], "summary": "Gainers\nCasa Systems, Inc.   ( NASDAQ: CASA )  shares surged 82.5% to close at $7.10 on Monday after the company announced a multi-year contract with Verizon to provide 5G core network functions.\nEnservco Corporation  ( NASDAQ: ENSV )  climbed 38% to settle at $3.63 on Monday. Enservco delayed filin", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/19/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "IPO", "relevance_score": "0.158519"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.87644"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Earnings", "relevance_score": "0.95493"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.010045, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "EDRY", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003124", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBI", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001637", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.085416", "ticker_sentiment_score": "0.00497", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002821", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARQQ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000308", "ticker_sentiment_label": "Neutral"}, {"ticker": "TGTX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.0006", "ticker_sentiment_label": "Neutral"}, {"ticker": "AZYO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002612", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIRX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001993", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZVO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.006272", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIXT", "relevance_score": "0.085416", "ticker_sentiment_score": "0.001798", "ticker_sentiment_label": "Neutral"}, {"ticker": "VERU", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000172", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINO", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002188", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYT", "relevance_score": "0.085416", "ticker_sentiment_score": "0.113743", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000299", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSS", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.018119", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002905", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.085416", "ticker_sentiment_score": "0.000669", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTEK", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001846", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003249", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000131", "ticker_sentiment_label": "Neutral"}, {"ticker": "KAVL", "relevance_score": "0.085416", "ticker_sentiment_score": "0.009867", "ticker_sentiment_label": "Neutral"}, {"ticker": "NUTX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000452", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNCE", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001285", "ticker_sentiment_label": "Neutral"}, {"ticker": "CASA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.0086", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.001918", "ticker_sentiment_label": "Neutral"}, {"ticker": "BDSX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000381", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000159", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATER", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003917", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTUS", "relevance_score": "0.057004", "ticker_sentiment_score": "0.005682", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMNM", "relevance_score": "0.085416", "ticker_sentiment_score": "-0.017969", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZ", "relevance_score": "0.02852", "ticker_sentiment_score": "0.0086", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001438", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADXN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.007534", "ticker_sentiment_label": "Neutral"}, {"ticker": "HDB", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.000882", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVDA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.01666", "ticker_sentiment_label": "Neutral"}, {"ticker": "WE", "relevance_score": "0.02852", "ticker_sentiment_score": "-0.000558", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVIV", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.00454", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.057004", "ticker_sentiment_score": "0.003101", "ticker_sentiment_label": "Neutral"}, {"ticker": "DFFN", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000411", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.085416", "ticker_sentiment_score": "-0.000746", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00114", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.113718", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "GBIO", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.002836", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.057004", "ticker_sentiment_score": "0.002163", "ticker_sentiment_label": "Neutral"}, {"ticker": "WRAP", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00701", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCFC", "relevance_score": "0.057004", "ticker_sentiment_score": "0.020699", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRSN", "relevance_score": "0.085416", "ticker_sentiment_score": "0.001752", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000877", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000318", "ticker_sentiment_label": "Neutral"}, {"ticker": "DIDI", "relevance_score": "0.085416", "ticker_sentiment_score": "0.002509", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCM", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001358", "ticker_sentiment_label": "Neutral"}, {"ticker": "GS", "relevance_score": "0.02852", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "INKT", "relevance_score": "0.057004", "ticker_sentiment_score": "0.00064", "ticker_sentiment_label": "Neutral"}, {"ticker": "USER", "relevance_score": "0.057004", "ticker_sentiment_score": "0.001322", "ticker_sentiment_label": "Neutral"}, {"ticker": "BMY", "relevance_score": "0.02852", "ticker_sentiment_score": "0.006314", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.004451", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMRA", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000897", "ticker_sentiment_label": "Neutral"}, {"ticker": "GGR", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000559", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELP", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.005015", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCHW", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.540526", "ticker_sentiment_label": "Bearish"}, {"ticker": "APCX", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLBZ", "relevance_score": "0.057004", "ticker_sentiment_score": "0.000465", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBGI", "relevance_score": "0.057004", "ticker_sentiment_score": "-0.06373", "ticker_sentiment_label": "Neutral"}]}, {"title": "51 Biggest Movers From Thursday", "url": "https://www.benzinga.com/news/22/04/26660206/51-biggest-movers-from-thursday", "time_published": "20220418T092156", "authors": [], "summary": "Gainers\nMedAvail Holdings, Inc.  ( NASDAQ: MDVL )  shares surged 69.4% to close at $2.44 on Thursday. Ally Bridge Group recently reported a purchase of 21.176 million shares of MedAvail Holdings for an average price of $1.06 per share.\nIndonesia Energy Corporation Limited  ( NYSE: INDO )  gained 65.", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2022/04/18/yesterdays_movers.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.2"}, {"topic": "Energy & Transportation", "relevance_score": "0.2"}, {"topic": "Technology", "relevance_score": "0.2"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Financial Markets", "relevance_score": "0.977154"}, {"topic": "Manufacturing", "relevance_score": "0.2"}, {"topic": "Earnings", "relevance_score": "0.538269"}, {"topic": "Real Estate & Construction", "relevance_score": "0.2"}], "overall_sentiment_score": -0.008156, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "RERE", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.009222", "ticker_sentiment_label": "Neutral"}, {"ticker": "CXW", "relevance_score": "0.069495", "ticker_sentiment_score": "0.006683", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMPP", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004891", "ticker_sentiment_label": "Neutral"}, {"ticker": "INZY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002125", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000385", "ticker_sentiment_label": "Neutral"}, {"ticker": "SISI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002285", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002226", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003169", "ticker_sentiment_label": "Neutral"}, {"ticker": "AREB", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000599", "ticker_sentiment_label": "Neutral"}, {"ticker": "GMBL", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.179891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AMST", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004151", "ticker_sentiment_label": "Neutral"}, {"ticker": "RENN", "relevance_score": "0.104078", "ticker_sentiment_score": "0.005536", "ticker_sentiment_label": "Neutral"}, {"ticker": "TRVI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.001156", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEGG", "relevance_score": "0.03478", "ticker_sentiment_score": "0.001193", "ticker_sentiment_label": "Neutral"}, {"ticker": "LEXX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.016523", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIXT", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002709", "ticker_sentiment_label": "Neutral"}, {"ticker": "MARPS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002277", "ticker_sentiment_label": "Neutral"}, {"ticker": "REDU", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000271", "ticker_sentiment_label": "Neutral"}, {"ticker": "IO", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.01962", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRDL", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003731", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDVL", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002027", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMBM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.00304", "ticker_sentiment_label": "Neutral"}, {"ticker": "AYLA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.005009", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRXT", "relevance_score": "0.069495", "ticker_sentiment_score": "0.002947", "ticker_sentiment_label": "Neutral"}, {"ticker": "WORX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.008007", "ticker_sentiment_label": "Neutral"}, {"ticker": "RVSN", "relevance_score": "0.069495", "ticker_sentiment_score": "0.0022", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000805", "ticker_sentiment_label": "Neutral"}, {"ticker": "TANH", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001258", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIRG", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009842", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLAR", "relevance_score": "0.03478", "ticker_sentiment_score": "0.002947", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLRB", "relevance_score": "0.104078", "ticker_sentiment_score": "0.01947", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGLY", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001109", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTGX", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.009024", "ticker_sentiment_label": "Neutral"}, {"ticker": "QCOM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009192", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEXT", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001572", "ticker_sentiment_label": "Neutral"}, {"ticker": "CISO", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001036", "ticker_sentiment_label": "Neutral"}, {"ticker": "VSTM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.006287", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYRA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003235", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000993", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFRI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.007446", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001345", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFAI", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002048", "ticker_sentiment_label": "Neutral"}, {"ticker": "HSTO", "relevance_score": "0.069495", "ticker_sentiment_score": "-1.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLSE", "relevance_score": "0.03478", "ticker_sentiment_score": "-0.179891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "BRQS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.009192", "ticker_sentiment_label": "Neutral"}, {"ticker": "CMLS", "relevance_score": "0.069495", "ticker_sentiment_score": "0.004472", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOL", "relevance_score": "0.069495", "ticker_sentiment_score": "-0.075334", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBFM", "relevance_score": "0.069495", "ticker_sentiment_score": "0.000545", "ticker_sentiment_label": "Neutral"}, {"ticker": "SYTA", "relevance_score": "0.069495", "ticker_sentiment_score": "0.001243", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARTL", "relevance_score": "0.104078", "ticker_sentiment_score": "0.002026", "ticker_sentiment_label": "Neutral"}, {"ticker": "APCX", "relevance_score": "0.069495", "ticker_sentiment_score": "0.003281", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRYPTO:NANO", "relevance_score": "0.03478", "ticker_sentiment_score": "0.002277", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Leadership Changes", "url": "https://www.globenewswire.com/news-release/2022/04/13/2421745/0/en/Pyxis-Oncology-Announces-Leadership-Changes.html", "time_published": "20220413T103500", "authors": ["Pyxis Oncology"], "summary": "- Ronald Herbst, Ph.D., stepping down as Chief Scientific Officer -", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.5"}, {"topic": "Technology", "relevance_score": "0.5"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.27442, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IMGN", "relevance_score": "0.03368", "ticker_sentiment_score": "0.014874", "ticker_sentiment_label": "Neutral"}, {"ticker": "IREHF", "relevance_score": "0.03368", "ticker_sentiment_score": "0.158098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.327149", "ticker_sentiment_score": "0.366789", "ticker_sentiment_label": "Bullish"}, {"ticker": "MGTA", "relevance_score": "0.067299", "ticker_sentiment_score": "0.014874", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMGN", "relevance_score": "0.03368", "ticker_sentiment_score": "0.014874", "ticker_sentiment_label": "Neutral"}, {"ticker": "PFE", "relevance_score": "0.03368", "ticker_sentiment_score": "0.855864", "ticker_sentiment_label": "Bullish"}]}, {"title": "Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T  ( PYX-106 )  Presented by Biosion, Inc. at the 2022 American Association for Cancer Research  ( AACR )  Annual Meeting", "url": "https://www.benzinga.com/pressreleases/22/04/g26549673/pyxis-oncology-announces-preclinical-data-on-anti-siglec-15-bsi-060t-pyx-106-presented-by-biosion-", "time_published": "20220408T170500", "authors": ["Globe Newswire"], "summary": "- Data highlight PYX-106's differentiated activity profile and antitumor activity in an in vivo mouse model -\n- Preclinical data support IND filing in 2H 2022 -\nCAMBRIDGE, Mass. and NEWARK, Del. and NANJING, China, April  08, 2022   ( GLOBE NEWSWIRE )  -- Pyxis Oncology, Inc.  ( NASDAQ:PYXS )  today", "banner_image": "https://ml.globenewswire.com/media/dc89ff40-4e91-444f-9ffd-3d68093dc029/small/full-color-png.png", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.124584, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.049547", "ticker_sentiment_score": "0.126674", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.336411", "ticker_sentiment_score": "0.14446", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Announces Preclinical Data on Anti-Siglec-15 BSI-060T  ( PYX-106 )  Presented by Biosion, Inc. at the 2022 American Association for Cancer Research  ( AACR )  Annual Meeting", "url": "https://www.globenewswire.com/news-release/2022/04/08/2419469/0/en/Pyxis-Oncology-Announces-Preclinical-Data-on-Anti-Siglec-15-BSI-060T-PYX-106-Presented-by-Biosion-Inc-at-the-2022-American-Association-for-Cancer-Research-AACR-Annual-Meeting.html", "time_published": "20220408T170500", "authors": ["Pyxis Oncology"], "summary": "- Data highlight PYX-106's differentiated activity profile and antitumor activity in an in vivo mouse model -", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.310843"}], "overall_sentiment_score": 0.06865, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.037253", "ticker_sentiment_score": "0.158098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.220709", "ticker_sentiment_score": "0.152378", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/04/26453944/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220404T160501", "authors": [], "summary": "On Monday, 78 companies set new 52-week lows.\nKey Facts About Today's 52-Week Lows:\nCitigroup  ( NYSE:C )  was the biggest company by market cap to set a new 52-week low.\nThe smallest company by market cap to set a new 52-week low was Evoke Pharma  ( NASDAQ:EVOK ) .\nCuris  ( NASDAQ:CRIS )  saw the m", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5775.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.019937, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "VINC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.017247", "ticker_sentiment_label": "Neutral"}, {"ticker": "FEIM", "relevance_score": "0.062934", "ticker_sentiment_score": "-0.032836", "ticker_sentiment_label": "Neutral"}, {"ticker": "FBC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.00058", "ticker_sentiment_label": "Neutral"}, {"ticker": "TEX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.032916", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.007118", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOOR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000227", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.014135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.125477", "ticker_sentiment_score": "-0.061449", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.015837", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.253181", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ANNX", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.008559", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEC", "relevance_score": "0.031491", "ticker_sentiment_score": "0.002244", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSBK", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.007658", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.002794", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003788", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.011012", "ticker_sentiment_label": "Neutral"}, {"ticker": "GHLD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001516", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.204262", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CLXT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.0001", "ticker_sentiment_label": "Neutral"}, {"ticker": "TKR", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.016899", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTH", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.008596", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLIC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.015895", "ticker_sentiment_label": "Neutral"}, {"ticker": "B", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.00053", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.062934", "ticker_sentiment_score": "0.022033", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.031491", "ticker_sentiment_score": "0.00439", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTIC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.292684", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CRIS", "relevance_score": "0.062934", "ticker_sentiment_score": "-0.006307", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.031491", "ticker_sentiment_score": "0.020163", "ticker_sentiment_label": "Neutral"}, {"ticker": "FCCO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.0064", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNSE", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001199", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003996", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.062934", "ticker_sentiment_score": "0.00096", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.007292", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.031491", "ticker_sentiment_score": "0.002667", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.031491", "ticker_sentiment_score": "0.000889", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.014742", "ticker_sentiment_label": "Neutral"}, {"ticker": "PPBI", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.202661", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "WDFC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.01193", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.003775", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVOK", "relevance_score": "0.062934", "ticker_sentiment_score": "0.018504", "ticker_sentiment_label": "Neutral"}, {"ticker": "SFNC", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.217343", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RAD", "relevance_score": "0.031491", "ticker_sentiment_score": "0.004415", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSCP", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000827", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.031491", "ticker_sentiment_score": "0.004848", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.006225", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.031491", "ticker_sentiment_score": "0.003408", "ticker_sentiment_label": "Neutral"}, {"ticker": "COLB", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.003367", "ticker_sentiment_label": "Neutral"}, {"ticker": "BVS", "relevance_score": "0.031491", "ticker_sentiment_score": "0.014542", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.031491", "ticker_sentiment_score": "-0.000502", "ticker_sentiment_label": "Neutral"}, {"ticker": "XPON", "relevance_score": "0.031491", "ticker_sentiment_score": "0.001664", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Friday", "url": "https://www.benzinga.com/news/22/04/26425809/stocks-that-hit-52-week-lows-on-friday", "time_published": "20220401T170001", "authors": [], "summary": "On Friday, 111 companies set new 52-week lows.\nInteresting Points From Today's 52-Week Lows:\nThe largest company by market cap to set a new 52-week low was Citigroup  ( NYSE:C ) .\nGeovax Labs  ( NASDAQ:GOVX )  was the smallest firm by market cap to set a new 52-week low.\nSELLAS Life Sciences Gr  ( N", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5685.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.015894, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MTH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000861", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.198155", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "GRPH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006129", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGY", "relevance_score": "0.021113", "ticker_sentiment_score": "0.004066", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000111", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOVX", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.121553", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLAP", "relevance_score": "0.021113", "ticker_sentiment_score": "0.007685", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.017968", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCRD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006299", "ticker_sentiment_label": "Neutral"}, {"ticker": "MDC", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001952", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATK", "relevance_score": "0.021113", "ticker_sentiment_score": "0.016351", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBBK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.013715", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTW", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000115", "ticker_sentiment_label": "Neutral"}, {"ticker": "CGEM", "relevance_score": "0.021113", "ticker_sentiment_score": "0.006592", "ticker_sentiment_label": "Neutral"}, {"ticker": "EVFM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002831", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACOR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009276", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLS", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.047335", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKE", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006079", "ticker_sentiment_label": "Neutral"}, {"ticker": "OMGA", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00889", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002155", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00755", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.016182", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.021707", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTLD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001305", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFBK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.013715", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.026488", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.010823", "ticker_sentiment_label": "Neutral"}, {"ticker": "HOVNP", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009254", "ticker_sentiment_label": "Neutral"}, {"ticker": "AEO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00075", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.021113", "ticker_sentiment_score": "-9.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "PKOH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.150414", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "POWL", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000735", "ticker_sentiment_label": "Neutral"}, {"ticker": "BCS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.020215", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.021113", "ticker_sentiment_score": "0.020126", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000387", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00077", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLXT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002867", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMRT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.004158", "ticker_sentiment_label": "Neutral"}, {"ticker": "SAH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.009071", "ticker_sentiment_label": "Neutral"}, {"ticker": "MAS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.004525", "ticker_sentiment_label": "Neutral"}, {"ticker": "ERAS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002073", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005319", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.06328", "ticker_sentiment_score": "0.016609", "ticker_sentiment_label": "Neutral"}, {"ticker": "GALT", "relevance_score": "0.021113", "ticker_sentiment_score": "0.0243", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLF", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006385", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.006704", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.011622", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002989", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000119", "ticker_sentiment_label": "Neutral"}, {"ticker": "STSA", "relevance_score": "0.042211", "ticker_sentiment_score": "-0.026398", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.021113", "ticker_sentiment_score": "-3.3e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXPI", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000928", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.021113", "ticker_sentiment_score": "0.010369", "ticker_sentiment_label": "Neutral"}, {"ticker": "IESC", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001864", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002127", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.003882", "ticker_sentiment_label": "Neutral"}, {"ticker": "JELD", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.217771", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PHM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.156253", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CWH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.001797", "ticker_sentiment_label": "Neutral"}, {"ticker": "WBA", "relevance_score": "0.021113", "ticker_sentiment_score": "2.6e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "HLTH", "relevance_score": "0.021113", "ticker_sentiment_score": "0.012276", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.050685", "ticker_sentiment_label": "Neutral"}, {"ticker": "THO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000532", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.007954", "ticker_sentiment_label": "Neutral"}, {"ticker": "JHX", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001182", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFIB", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.000574", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.021113", "ticker_sentiment_score": "0.000606", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNW", "relevance_score": "0.021113", "ticker_sentiment_score": "0.002408", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.023036", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAB", "relevance_score": "0.021113", "ticker_sentiment_score": "0.005009", "ticker_sentiment_label": "Neutral"}, {"ticker": "LSTR", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.003393", "ticker_sentiment_label": "Neutral"}, {"ticker": "QNGY", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001325", "ticker_sentiment_label": "Neutral"}, {"ticker": "BRQS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.035112", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYTS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.214347", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "CCS", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.007266", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.001657", "ticker_sentiment_label": "Neutral"}, {"ticker": "RAD", "relevance_score": "0.021113", "ticker_sentiment_score": "0.004367", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSCP", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.002927", "ticker_sentiment_label": "Neutral"}, {"ticker": "LYLT", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005786", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKBA", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.00445", "ticker_sentiment_label": "Neutral"}, {"ticker": "FWBI", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.005656", "ticker_sentiment_label": "Neutral"}, {"ticker": "HZO", "relevance_score": "0.021113", "ticker_sentiment_score": "0.016823", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRO", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.023391", "ticker_sentiment_label": "Neutral"}, {"ticker": "MINM", "relevance_score": "0.021113", "ticker_sentiment_score": "-0.353061", "ticker_sentiment_label": "Bearish"}]}, {"title": "Stocks That Hit 52-Week Lows On Thursday", "url": "https://www.benzinga.com/news/22/03/26401822/stocks-that-hit-52-week-lows-on-thursday", "time_published": "20220331T181044", "authors": [], "summary": "On Thursday, 92 companies hit new 52-week lows.\nAreas of Interest About Today's 52-Week Lows:\nThe largest company in terms of market cap to set a new 52-week low was UiPath  ( NYSE:PATH ) .\nThe smallest company by market cap to set a new 52-week low was Stryve Foods  ( NASDAQ:SNAX ) .\nMotorsport Gam", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_5580.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "0.999999"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.001059, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "MTH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.006838", "ticker_sentiment_label": "Neutral"}, {"ticker": "PATH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.026483", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVAH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.014045", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRPH", "relevance_score": "0.02511", "ticker_sentiment_score": "0.013945", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.0019", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBD", "relevance_score": "0.02511", "ticker_sentiment_score": "0.029993", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.02511", "ticker_sentiment_score": "0.002284", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLTA", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006696", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.01472", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001113", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGI", "relevance_score": "0.02511", "ticker_sentiment_score": "0.008988", "ticker_sentiment_label": "Neutral"}, {"ticker": "AXDX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.155634", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "ADAG", "relevance_score": "0.02511", "ticker_sentiment_score": "0.001066", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.020873", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006959", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOB", "relevance_score": "0.02511", "ticker_sentiment_score": "-9.9e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.006173", "ticker_sentiment_label": "Neutral"}, {"ticker": "WHR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000273", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHCR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.021348", "ticker_sentiment_label": "Neutral"}, {"ticker": "WERN", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.005365", "ticker_sentiment_label": "Neutral"}, {"ticker": "FGF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.016643", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSGM", "relevance_score": "0.050196", "ticker_sentiment_score": "0.017922", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANNX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.025102", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURV", "relevance_score": "0.02511", "ticker_sentiment_score": "0.005197", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSI", "relevance_score": "0.02511", "ticker_sentiment_score": "0.001503", "ticker_sentiment_label": "Neutral"}, {"ticker": "MEC", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.002252", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.02511", "ticker_sentiment_score": "-5.8e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACLX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004309", "ticker_sentiment_label": "Neutral"}, {"ticker": "POWL", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004439", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.009635", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001495", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNSO", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.029687", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALVR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.233716", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "XBIT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000461", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTE", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001591", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.029899", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROCK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001965", "ticker_sentiment_label": "Neutral"}, {"ticker": "GFF", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.013543", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000518", "ticker_sentiment_label": "Neutral"}, {"ticker": "WVE", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003776", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALGS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000663", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000341", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONL", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000363", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNBR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003305", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBH", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.011112", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASUR", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.278331", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IXHL", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.005271", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGRY", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000209", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRBK", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001224", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSAT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.25481", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "THO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.00196", "ticker_sentiment_label": "Neutral"}, {"ticker": "XLO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.004944", "ticker_sentiment_label": "Neutral"}, {"ticker": "ABOS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.010579", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBLN", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.009057", "ticker_sentiment_label": "Neutral"}, {"ticker": "TPX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.008903", "ticker_sentiment_label": "Neutral"}, {"ticker": "CXDO", "relevance_score": "0.02511", "ticker_sentiment_score": "0.568918", "ticker_sentiment_label": "Bullish"}, {"ticker": "PYXS", "relevance_score": "0.02511", "ticker_sentiment_score": "0.002703", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.000723", "ticker_sentiment_label": "Neutral"}, {"ticker": "HMTV", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.001988", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.003724", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWM", "relevance_score": "0.02511", "ticker_sentiment_score": "-6.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOTZ", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.004098", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGRX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.019169", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.025521", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNED", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000152", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.02511", "ticker_sentiment_score": "0.021484", "ticker_sentiment_label": "Neutral"}, {"ticker": "LZB", "relevance_score": "0.02511", "ticker_sentiment_score": "0.000725", "ticker_sentiment_label": "Neutral"}, {"ticker": "WLFC", "relevance_score": "0.02511", "ticker_sentiment_score": "0.003987", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAS", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.013642", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.02511", "ticker_sentiment_score": "0.006148", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMBCV", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.015329", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBNT", "relevance_score": "0.02511", "ticker_sentiment_score": "-0.01874", "ticker_sentiment_label": "Neutral"}]}, {"title": "51 Biggest Movers From Yesterday", "url": "https://www.benzinga.com/news/22/03/26390922/51-biggest-movers-from-yesterday", "time_published": "20220331T094126", "authors": [], "summary": "Gainers\nForge Global Holdings, Inc.  ( NYSE: FRGE )  jumped 73.9% to close at $37.64.\nDirect Digital Holdings, Inc.  ( NASDAQ: DRCT )  shares surged 60.5% to close at $4.14 on Wednesday after the company reported a year over year increase in Q4 sales results and issued Q1 sales guidance above analys", "banner_image": "https://cdn.benzinga.com/files/imagecache/og_image_social_share_1200x630/images/story/2012/yesterdays_movers_423.png", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.166667"}, {"topic": "Technology", "relevance_score": "0.166667"}, {"topic": "Finance", "relevance_score": "0.166667"}, {"topic": "IPO", "relevance_score": "0.310843"}, {"topic": "Retail & Wholesale", "relevance_score": "0.166667"}, {"topic": "Financial Markets", "relevance_score": "0.905476"}, {"topic": "Manufacturing", "relevance_score": "0.166667"}, {"topic": "Earnings", "relevance_score": "0.997335"}, {"topic": "Real Estate & Construction", "relevance_score": "0.166667"}], "overall_sentiment_score": -0.057379, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "APO", "relevance_score": "0.035902", "ticker_sentiment_score": "-0.015014", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEAR", "relevance_score": "0.071731", "ticker_sentiment_score": "0.009391", "ticker_sentiment_label": "Neutral"}, {"ticker": "SGHT", "relevance_score": "0.107415", "ticker_sentiment_score": "0.0004", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBBY", "relevance_score": "0.107415", "ticker_sentiment_score": "0.00544", "ticker_sentiment_label": "Neutral"}, {"ticker": "SDIG", "relevance_score": "0.071731", "ticker_sentiment_score": "-0.617218", "ticker_sentiment_label": "Bearish"}, {"ticker": "INFI", "relevance_score": "0.071731", "ticker_sentiment_score": "0.005098", "ticker_sentiment_label": "Neutral"}, {"ticker": "FRGE", "relevance_score": "0.071731", "ticker_sentiment_score": "0.004448", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOA", "relevance_score": "0.107415", "ticker_sentiment_score": "0.01719", "ticker_sentiment_label": "Neutral"}, {"ticker": "CALA", "relevance_score": "0.071731", "ticker_sentiment_score": "0.00109", "ticker_sentiment_label": "Neutral"}, {"ticker": "UPH", "relevance_score": "0.071731", "ticker_sentiment_score": "-0.513414", "ticker_sentiment_label": "Bearish"}, {"ticker": "COMS", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000597", "ticker_sentiment_label": "Neutral"}, {"ticker": "LLL", "relevance_score": "0.071731", "ticker_sentiment_score": "0.001976", "ticker_sentiment_label": "Neutral"}, {"ticker": "MULN", "relevance_score": "0.071731", "ticker_sentiment_score": "0.005504", "ticker_sentiment_label": "Neutral"}, {"ticker": "VLNS", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000773", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTIB", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000916", "ticker_sentiment_label": "Neutral"}, {"ticker": "LITM", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000705", "ticker_sentiment_label": "Neutral"}, {"ticker": "CHWY", "relevance_score": "0.071731", "ticker_sentiment_score": "-0.450943", "ticker_sentiment_label": "Bearish"}, {"ticker": "ADGI", "relevance_score": "0.071731", "ticker_sentiment_score": "0.01497", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOGZ", "relevance_score": "0.071731", "ticker_sentiment_score": "0.00164", "ticker_sentiment_label": "Neutral"}, {"ticker": "FSRD", "relevance_score": "0.071731", "ticker_sentiment_score": "0.00544", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.107415", "ticker_sentiment_score": "-0.002495", "ticker_sentiment_label": "Neutral"}, {"ticker": "VYNT", "relevance_score": "0.107415", "ticker_sentiment_score": "0.03687", "ticker_sentiment_label": "Neutral"}, {"ticker": "INAB", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000893", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRAD", "relevance_score": "0.071731", "ticker_sentiment_score": "0.045001", "ticker_sentiment_label": "Neutral"}, {"ticker": "HILS", "relevance_score": "0.071731", "ticker_sentiment_score": "0.011013", "ticker_sentiment_label": "Neutral"}, {"ticker": "LCFY", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "ISIG", "relevance_score": "0.071731", "ticker_sentiment_score": "0.004571", "ticker_sentiment_label": "Neutral"}, {"ticker": "OBLG", "relevance_score": "0.107415", "ticker_sentiment_score": "-0.021398", "ticker_sentiment_label": "Neutral"}, {"ticker": "MREO", "relevance_score": "0.071731", "ticker_sentiment_score": "0.003209", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMC", "relevance_score": "0.071731", "ticker_sentiment_score": "0.007942", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCM", "relevance_score": "0.071731", "ticker_sentiment_score": "0.001604", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPGN", "relevance_score": "0.071731", "ticker_sentiment_score": "0.001023", "ticker_sentiment_label": "Neutral"}, {"ticker": "PSO", "relevance_score": "0.107415", "ticker_sentiment_score": "-0.015014", "ticker_sentiment_label": "Neutral"}, {"ticker": "MVST", "relevance_score": "0.071731", "ticker_sentiment_score": "0.001193", "ticker_sentiment_label": "Neutral"}, {"ticker": "LULU", "relevance_score": "0.071731", "ticker_sentiment_score": "0.006148", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMBC", "relevance_score": "0.071731", "ticker_sentiment_score": "0.002276", "ticker_sentiment_label": "Neutral"}, {"ticker": "CONN", "relevance_score": "0.107415", "ticker_sentiment_score": "-0.017088", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000139", "ticker_sentiment_label": "Neutral"}, {"ticker": "REED", "relevance_score": "0.107415", "ticker_sentiment_score": "0.007812", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNAX", "relevance_score": "0.071731", "ticker_sentiment_score": "0.004828", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.071731", "ticker_sentiment_score": "-0.765492", "ticker_sentiment_label": "Bearish"}, {"ticker": "AKBA", "relevance_score": "0.071731", "ticker_sentiment_score": "0.000971", "ticker_sentiment_label": "Neutral"}, {"ticker": "BBAI", "relevance_score": "0.071731", "ticker_sentiment_score": "0.001891", "ticker_sentiment_label": "Neutral"}, {"ticker": "REVB", "relevance_score": "0.071731", "ticker_sentiment_score": "-0.018314", "ticker_sentiment_label": "Neutral"}, {"ticker": "GERN", "relevance_score": "0.071731", "ticker_sentiment_score": "0.022692", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAOV", "relevance_score": "0.035902", "ticker_sentiment_score": "0.020422", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIR", "relevance_score": "0.107415", "ticker_sentiment_score": "0.006076", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology In-Licenses Anti-Siglec-15 Monoclonal Antibody From Biosion", "url": "https://www.benzinga.com/general/biotech/22/03/26356373/pyxis-oncology-in-licenses-anti-siglec-15-monoclonal-antibody-from-biosion", "time_published": "20220329T174418", "authors": ["Vandana Singh"], "summary": "Pyxis Oncology Inc  ( NASDAQ: PYXS )  has received an exclusive license to develop and commercialize Biosion Inc's anti-Siglec-15 monoclonal antibody, BSI-060T  ( now referred to as PYX-106 ) , worldwide, excluding Greater China. \nUnder the agreement terms, Biosion will ...Full story available on Be", "banner_image": "https://cdn.benzinga.com/files/images/story/2012/aapharma_4022.png?width=1200&height=800&fit=crop", "source": "Benzinga", "category_within_source": "General", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": -0.019435, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PYXS", "relevance_score": "0.932919", "ticker_sentiment_score": "0.015544", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology Provides Corporate and Financial Update", "url": "https://www.globenewswire.com/news-release/2022/03/29/2411693/0/en/Pyxis-Oncology-Provides-Corporate-and-Financial-Update.html", "time_published": "20220329T103500", "authors": ["Pyxis Oncology"], "summary": "Announces Expansion of Novel Immuno-Oncology Therapeutic Portfolio with Addition of Anti-Siglec-15 In-licensed from Biosion  ( PYX-106 )", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Earnings", "relevance_score": "0.310843"}, {"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.538269"}], "overall_sentiment_score": 0.258968, "overall_sentiment_label": "Somewhat-Bullish", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.033111", "ticker_sentiment_score": "0.14774", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.493422", "ticker_sentiment_score": "0.258968", "ticker_sentiment_label": "Somewhat-Bullish"}]}, {"title": "Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022", "url": "https://www.globenewswire.com/news-release/2022/03/22/2407381/0/en/Pyxis-Oncology-to-Host-Corporate-Update-Conference-Call-and-Webcast-on-March-29-2022.html", "time_published": "20220322T103500", "authors": ["Pyxis Oncology"], "summary": "CAMBRIDGE, Mass., March  22, 2022   ( GLOBE NEWSWIRE )  -- Pyxis Oncology, Inc.  ( Nasdaq: PYXS ) , a multi-asset, multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced it will host a conference call and live webcast on Tuesday, Mar", "banner_image": "https://ml.globenewswire.com/Resource/Download/dc89ff40-4e91-444f-9ffd-3d68093dc029?size=1", "source": "GlobeNewswire", "category_within_source": "n/a", "source_domain": "www.globenewswire.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}], "overall_sentiment_score": 0.093827, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.158207", "ticker_sentiment_score": "0.158098", "ticker_sentiment_label": "Somewhat-Bullish"}, {"ticker": "PYXS", "relevance_score": "0.768929", "ticker_sentiment_score": "0.093827", "ticker_sentiment_label": "Neutral"}]}, {"title": "Pyxis Oncology to Host Corporate Update Conference Call and Webcast on March 29, 2022", "url": "https://www.benzinga.com/pressreleases/22/03/g26234857/pyxis-oncology-to-host-corporate-update-conference-call-and-webcast-on-march-29-2022", "time_published": "20220322T103500", "authors": ["Globe Newswire"], "summary": "CAMBRIDGE, Mass., March  22, 2022   ( GLOBE NEWSWIRE )  -- Pyxis Oncology, Inc.  ( NASDAQ:PYXS ) , a multi-asset, multi-modality company focused on developing next-generation therapeutics for difficult to treat cancers, today announced it will host a conference call and live webcast on Tuesday, Marc", "banner_image": "https://ml.globenewswire.com/media/dc89ff40-4e91-444f-9ffd-3d68093dc029/small/full-color-png.png", "source": "Benzinga", "category_within_source": "News", "source_domain": "www.benzinga.com", "topics": [{"topic": "Technology", "relevance_score": "1.0"}, {"topic": "Financial Markets", "relevance_score": "0.214378"}], "overall_sentiment_score": 0.132674, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "IREHF", "relevance_score": "0.096827", "ticker_sentiment_score": "0.126674", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.534565", "ticker_sentiment_score": "0.076913", "ticker_sentiment_label": "Neutral"}]}, {"title": "Stocks That Hit 52-Week Lows On Monday", "url": "https://www.benzinga.com/news/22/03/26125409/stocks-that-hit-52-week-lows-on-monday", "time_published": "20220314T161153", "authors": [], "summary": "On Monday, 671 companies achieved new lows for the year.\nPoints of Interest From Today's 52-Week Lows:\nAlibaba Group Holding  ( NYSE:BABA )  was the largest firm by market cap to set a new 52-week low.\nThe company with the smallest market cap to set a new 52-week low was Reshape Lifesciences  ( NASD", "banner_image": "https://cdn.benzinga.com/files/imagecache/story_image_685x375C/images/story/2022/movers_image_4242.jpeg", "source": "Benzinga", "category_within_source": "Trading", "source_domain": "www.benzinga.com", "topics": [{"topic": "Life Sciences", "relevance_score": "0.142857"}, {"topic": "Energy & Transportation", "relevance_score": "0.142857"}, {"topic": "Technology", "relevance_score": "0.142857"}, {"topic": "Finance", "relevance_score": "0.142857"}, {"topic": "Retail & Wholesale", "relevance_score": "0.142857"}, {"topic": "Financial Markets", "relevance_score": "1.0"}, {"topic": "Manufacturing", "relevance_score": "0.142857"}, {"topic": "Real Estate & Construction", "relevance_score": "0.142857"}], "overall_sentiment_score": -0.011152, "overall_sentiment_label": "Neutral", "ticker_sentiment": [{"ticker": "PATH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003884", "ticker_sentiment_label": "Neutral"}, {"ticker": "AGLE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001398", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLWS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.2171", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FEIM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005288", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004681", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNTB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000696", "ticker_sentiment_label": "Neutral"}, {"ticker": "TIGR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005376", "ticker_sentiment_label": "Neutral"}, {"ticker": "LFC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001195", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002642", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCNC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002637", "ticker_sentiment_label": "Neutral"}, {"ticker": "WYNN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016064", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACTG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000542", "ticker_sentiment_label": "Neutral"}, {"ticker": "MTBC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000421", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROIV", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000629", "ticker_sentiment_label": "Neutral"}, {"ticker": "XNET", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00337", "ticker_sentiment_label": "Neutral"}, {"ticker": "VTGN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.013657", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015648", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002718", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007926", "ticker_sentiment_label": "Neutral"}, {"ticker": "NVTA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001817", "ticker_sentiment_label": "Neutral"}, {"ticker": "CUE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000373", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIASP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00185", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMSI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008021", "ticker_sentiment_label": "Neutral"}, {"ticker": "COUP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002201", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLQT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003108", "ticker_sentiment_label": "Neutral"}, {"ticker": "XMTR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012959", "ticker_sentiment_label": "Neutral"}, {"ticker": "BILI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016807", "ticker_sentiment_label": "Neutral"}, {"ticker": "INSG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004046", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTWO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005292", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.086934", "ticker_sentiment_label": "Neutral"}, {"ticker": "GME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003916", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMWL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.036134", "ticker_sentiment_label": "Neutral"}, {"ticker": "AB", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.00664", "ticker_sentiment_label": "Neutral"}, {"ticker": "WING", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000895", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007487", "ticker_sentiment_label": "Neutral"}, {"ticker": "AI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.013531", "ticker_sentiment_label": "Neutral"}, {"ticker": "MOXC", "relevance_score": "0.003772", "ticker_sentiment_score": "-1e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.007468", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARBE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001396", "ticker_sentiment_label": "Neutral"}, {"ticker": "NODK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002816", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMAR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003546", "ticker_sentiment_label": "Neutral"}, {"ticker": "EMKR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009121", "ticker_sentiment_label": "Neutral"}, {"ticker": "MILE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000833", "ticker_sentiment_label": "Neutral"}, {"ticker": "SURF", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002657", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOVO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015766", "ticker_sentiment_label": "Neutral"}, {"ticker": "KIRK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004298", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTNX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.023894", "ticker_sentiment_label": "Neutral"}, {"ticker": "CURI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.014346", "ticker_sentiment_label": "Neutral"}, {"ticker": "RH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002168", "ticker_sentiment_label": "Neutral"}, {"ticker": "NAII", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008781", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOFI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.030443", "ticker_sentiment_label": "Neutral"}, {"ticker": "IAS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BTBT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000338", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICLK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001946", "ticker_sentiment_label": "Neutral"}, {"ticker": "ASTE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002155", "ticker_sentiment_label": "Neutral"}, {"ticker": "FTFT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003706", "ticker_sentiment_label": "Neutral"}, {"ticker": "OLLI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005305", "ticker_sentiment_label": "Neutral"}, {"ticker": "ROKU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006016", "ticker_sentiment_label": "Neutral"}, {"ticker": "TXG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012121", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZEPP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.26753", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AIRG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003296", "ticker_sentiment_label": "Neutral"}, {"ticker": "C", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005562", "ticker_sentiment_label": "Neutral"}, {"ticker": "VITL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010979", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIOC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016062", "ticker_sentiment_label": "Neutral"}, {"ticker": "TBLA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000797", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDAY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002103", "ticker_sentiment_label": "Neutral"}, {"ticker": "COGT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000549", "ticker_sentiment_label": "Neutral"}, {"ticker": "LIAN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026157", "ticker_sentiment_label": "Neutral"}, {"ticker": "AOMR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001124", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031246", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAVM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001456", "ticker_sentiment_label": "Neutral"}, {"ticker": "BQ", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011731", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCAT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018211", "ticker_sentiment_label": "Neutral"}, {"ticker": "SOHU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000634", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYND", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004268", "ticker_sentiment_label": "Neutral"}, {"ticker": "INDP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006066", "ticker_sentiment_label": "Neutral"}, {"ticker": "S", "relevance_score": "0.003772", "ticker_sentiment_score": "0.017354", "ticker_sentiment_label": "Neutral"}, {"ticker": "YALA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001731", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKUS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001488", "ticker_sentiment_label": "Neutral"}, {"ticker": "LRCX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000985", "ticker_sentiment_label": "Neutral"}, {"ticker": "FREQ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001058", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZYXI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000317", "ticker_sentiment_label": "Neutral"}, {"ticker": "RDFN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000912", "ticker_sentiment_label": "Neutral"}, {"ticker": "THS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004609", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEEL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000744", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMED", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031218", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003476", "ticker_sentiment_label": "Neutral"}, {"ticker": "FLXS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000416", "ticker_sentiment_label": "Neutral"}, {"ticker": "ST", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003032", "ticker_sentiment_label": "Neutral"}, {"ticker": "WNW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007135", "ticker_sentiment_label": "Neutral"}, {"ticker": "TDOC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000708", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00181", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHM", "relevance_score": "0.003772", "ticker_sentiment_score": "4.7e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "SY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001944", "ticker_sentiment_label": "Neutral"}, {"ticker": "IMAB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011047", "ticker_sentiment_label": "Neutral"}, {"ticker": "STAA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.019391", "ticker_sentiment_label": "Neutral"}, {"ticker": "APPS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003501", "ticker_sentiment_label": "Neutral"}, {"ticker": "YSG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001442", "ticker_sentiment_label": "Neutral"}, {"ticker": "BKSY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00577", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNVY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.055909", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTRN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005562", "ticker_sentiment_label": "Neutral"}, {"ticker": "REE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.20535", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "AIRT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010498", "ticker_sentiment_label": "Neutral"}, {"ticker": "EHTH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012368", "ticker_sentiment_label": "Neutral"}, {"ticker": "CETX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000437", "ticker_sentiment_label": "Neutral"}, {"ticker": "STRO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014428", "ticker_sentiment_label": "Neutral"}, {"ticker": "ITI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001765", "ticker_sentiment_label": "Neutral"}, {"ticker": "TOUR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00485", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMFR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017855", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALZN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004668", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.0021", "ticker_sentiment_label": "Neutral"}, {"ticker": "ETNB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001462", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFI", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003591", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002065", "ticker_sentiment_label": "Neutral"}, {"ticker": "CANG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000198", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNLN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009292", "ticker_sentiment_label": "Neutral"}, {"ticker": "HBB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.014548", "ticker_sentiment_label": "Neutral"}, {"ticker": "PAY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003887", "ticker_sentiment_label": "Neutral"}, {"ticker": "BOLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010771", "ticker_sentiment_label": "Neutral"}, {"ticker": "INFI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005998", "ticker_sentiment_label": "Neutral"}, {"ticker": "COIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002295", "ticker_sentiment_label": "Neutral"}, {"ticker": "WISH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018453", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTSO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007713", "ticker_sentiment_label": "Neutral"}, {"ticker": "DV", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006021", "ticker_sentiment_label": "Neutral"}, {"ticker": "IDN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005693", "ticker_sentiment_label": "Neutral"}, {"ticker": "JWEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.010903", "ticker_sentiment_label": "Neutral"}, {"ticker": "UK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012282", "ticker_sentiment_label": "Neutral"}, {"ticker": "KSFTF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011045", "ticker_sentiment_label": "Neutral"}, {"ticker": "FENG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004916", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAPP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014836", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017551", "ticker_sentiment_label": "Neutral"}, {"ticker": "RFL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002186", "ticker_sentiment_label": "Neutral"}, {"ticker": "TMDI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00428", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIVN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000776", "ticker_sentiment_label": "Neutral"}, {"ticker": "XRAY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.019955", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATHX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012193", "ticker_sentiment_label": "Neutral"}, {"ticker": "ICAD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00234", "ticker_sentiment_label": "Neutral"}, {"ticker": "PIXY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007568", "ticker_sentiment_label": "Neutral"}, {"ticker": "BABA", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.082091", "ticker_sentiment_label": "Neutral"}, {"ticker": "DKNG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001945", "ticker_sentiment_label": "Neutral"}, {"ticker": "EH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002015", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCOM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.035733", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.012546", "ticker_sentiment_label": "Neutral"}, {"ticker": "BGS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.033258", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVLU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011865", "ticker_sentiment_label": "Neutral"}, {"ticker": "POSH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007586", "ticker_sentiment_label": "Neutral"}, {"ticker": "YMTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.157538", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "HCM", "relevance_score": "0.007545", "ticker_sentiment_score": "0.00015", "ticker_sentiment_label": "Neutral"}, {"ticker": "HCP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024422", "ticker_sentiment_label": "Neutral"}, {"ticker": "GRCL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015492", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONCT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01034", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000791", "ticker_sentiment_label": "Neutral"}, {"ticker": "DAKT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01273", "ticker_sentiment_label": "Neutral"}, {"ticker": "QRVO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008573", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002822", "ticker_sentiment_label": "Neutral"}, {"ticker": "STTK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.185347", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "IMVT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011815", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLOW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006276", "ticker_sentiment_label": "Neutral"}, {"ticker": "TZOO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00175", "ticker_sentiment_label": "Neutral"}, {"ticker": "BEKE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00369", "ticker_sentiment_label": "Neutral"}, {"ticker": "VZIO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006156", "ticker_sentiment_label": "Neutral"}, {"ticker": "FOSL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015294", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPNT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000436", "ticker_sentiment_label": "Neutral"}, {"ticker": "CLEU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017092", "ticker_sentiment_label": "Neutral"}, {"ticker": "PTON", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000792", "ticker_sentiment_label": "Neutral"}, {"ticker": "DOYU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.17358", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "OSPN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003938", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001017", "ticker_sentiment_label": "Neutral"}, {"ticker": "WB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001531", "ticker_sentiment_label": "Neutral"}, {"ticker": "IVZ", "relevance_score": "0.01886", "ticker_sentiment_score": "-0.000329", "ticker_sentiment_label": "Neutral"}, {"ticker": "MRTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006788", "ticker_sentiment_label": "Neutral"}, {"ticker": "BFLY", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003752", "ticker_sentiment_label": "Neutral"}, {"ticker": "LVOX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004313", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTES", "relevance_score": "0.003772", "ticker_sentiment_score": "0.01205", "ticker_sentiment_label": "Neutral"}, {"ticker": "PDD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.019435", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNSA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004339", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLGC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001895", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCRT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026404", "ticker_sentiment_label": "Neutral"}, {"ticker": "HUIZ", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002233", "ticker_sentiment_label": "Neutral"}, {"ticker": "NKTR", "relevance_score": "0.007545", "ticker_sentiment_score": "-0.005092", "ticker_sentiment_label": "Neutral"}, {"ticker": "GH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010687", "ticker_sentiment_label": "Neutral"}, {"ticker": "PYXS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000171", "ticker_sentiment_label": "Neutral"}, {"ticker": "ONEM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004359", "ticker_sentiment_label": "Neutral"}, {"ticker": "EXFY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003989", "ticker_sentiment_label": "Neutral"}, {"ticker": "SSSS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.19891", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "FWRG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000847", "ticker_sentiment_label": "Neutral"}, {"ticker": "QUMU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016747", "ticker_sentiment_label": "Neutral"}, {"ticker": "SWKS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016108", "ticker_sentiment_label": "Neutral"}, {"ticker": "BZUN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014003", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNLX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.014796", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALLR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.032201", "ticker_sentiment_label": "Neutral"}, {"ticker": "GREEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002703", "ticker_sentiment_label": "Neutral"}, {"ticker": "BYSI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000238", "ticker_sentiment_label": "Neutral"}, {"ticker": "ESMT", "relevance_score": "0.007545", "ticker_sentiment_score": "0.019141", "ticker_sentiment_label": "Neutral"}, {"ticker": "DNA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.006782", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSTGF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026571", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPNG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001942", "ticker_sentiment_label": "Neutral"}, {"ticker": "GTH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006324", "ticker_sentiment_label": "Neutral"}, {"ticker": "MKFG", "relevance_score": "0.003772", "ticker_sentiment_score": "0.027162", "ticker_sentiment_label": "Neutral"}, {"ticker": "SRRK", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000699", "ticker_sentiment_label": "Neutral"}, {"ticker": "BIDU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005157", "ticker_sentiment_label": "Neutral"}, {"ticker": "RIVN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001117", "ticker_sentiment_label": "Neutral"}, {"ticker": "KNDI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00019", "ticker_sentiment_label": "Neutral"}, {"ticker": "LOCO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.016003", "ticker_sentiment_label": "Neutral"}, {"ticker": "TCTZF", "relevance_score": "0.003772", "ticker_sentiment_score": "0.0249", "ticker_sentiment_label": "Neutral"}, {"ticker": "KLR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003942", "ticker_sentiment_label": "Neutral"}, {"ticker": "VRM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.021849", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDXC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000841", "ticker_sentiment_label": "Neutral"}, {"ticker": "COMM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002247", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBUX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004604", "ticker_sentiment_label": "Neutral"}, {"ticker": "IHS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000154", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTGR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.032621", "ticker_sentiment_label": "Neutral"}, {"ticker": "SCWX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000263", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002183", "ticker_sentiment_label": "Neutral"}, {"ticker": "CCEL", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003941", "ticker_sentiment_label": "Neutral"}, {"ticker": "WDH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000506", "ticker_sentiment_label": "Neutral"}, {"ticker": "GLMD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001887", "ticker_sentiment_label": "Neutral"}, {"ticker": "IH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000983", "ticker_sentiment_label": "Neutral"}, {"ticker": "AIH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005539", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMB", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003137", "ticker_sentiment_label": "Neutral"}, {"ticker": "CYRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000896", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPOT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002896", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYRE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.036623", "ticker_sentiment_label": "Neutral"}, {"ticker": "LMNR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000463", "ticker_sentiment_label": "Neutral"}, {"ticker": "RELY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004726", "ticker_sentiment_label": "Neutral"}, {"ticker": "IQ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007501", "ticker_sentiment_label": "Neutral"}, {"ticker": "RXRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010448", "ticker_sentiment_label": "Neutral"}, {"ticker": "SMG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007923", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000373", "ticker_sentiment_label": "Neutral"}, {"ticker": "HRTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005304", "ticker_sentiment_label": "Neutral"}, {"ticker": "UXIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005353", "ticker_sentiment_label": "Neutral"}, {"ticker": "FVRR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00436", "ticker_sentiment_label": "Neutral"}, {"ticker": "KMT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009461", "ticker_sentiment_label": "Neutral"}, {"ticker": "PCOR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004134", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001695", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRTO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004278", "ticker_sentiment_label": "Neutral"}, {"ticker": "PUBM", "relevance_score": "0.003772", "ticker_sentiment_score": "0.0049", "ticker_sentiment_label": "Neutral"}, {"ticker": "SBTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.037601", "ticker_sentiment_label": "Neutral"}, {"ticker": "APVO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.006064", "ticker_sentiment_label": "Neutral"}, {"ticker": "HTHT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003211", "ticker_sentiment_label": "Neutral"}, {"ticker": "EPIX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.24313", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "JD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000986", "ticker_sentiment_label": "Neutral"}, {"ticker": "SHPW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.015471", "ticker_sentiment_label": "Neutral"}, {"ticker": "NGMS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000371", "ticker_sentiment_label": "Neutral"}, {"ticker": "AFRM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026293", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.022996", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLK", "relevance_score": "0.101578", "ticker_sentiment_score": "-0.031418", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIDU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000849", "ticker_sentiment_label": "Neutral"}, {"ticker": "WKME", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00343", "ticker_sentiment_label": "Neutral"}, {"ticker": "CELC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002691", "ticker_sentiment_label": "Neutral"}, {"ticker": "JP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000603", "ticker_sentiment_label": "Neutral"}, {"ticker": "CNS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000409", "ticker_sentiment_label": "Neutral"}, {"ticker": "AERC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.021216", "ticker_sentiment_label": "Neutral"}, {"ticker": "NTP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001758", "ticker_sentiment_label": "Neutral"}, {"ticker": "NATI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000291", "ticker_sentiment_label": "Neutral"}, {"ticker": "KRNT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017566", "ticker_sentiment_label": "Neutral"}, {"ticker": "ATOM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.0052", "ticker_sentiment_label": "Neutral"}, {"ticker": "VNET", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005232", "ticker_sentiment_label": "Neutral"}, {"ticker": "SEMR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002206", "ticker_sentiment_label": "Neutral"}, {"ticker": "SKYT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.021636", "ticker_sentiment_label": "Neutral"}, {"ticker": "INMB", "relevance_score": "0.003772", "ticker_sentiment_score": "6.4e-05", "ticker_sentiment_label": "Neutral"}, {"ticker": "KC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011045", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACMR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001943", "ticker_sentiment_label": "Neutral"}, {"ticker": "SIEN", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001019", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPCE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002686", "ticker_sentiment_label": "Neutral"}, {"ticker": "MSA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000397", "ticker_sentiment_label": "Neutral"}, {"ticker": "PHR", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009274", "ticker_sentiment_label": "Neutral"}, {"ticker": "RLX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004006", "ticker_sentiment_label": "Neutral"}, {"ticker": "NFLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.009405", "ticker_sentiment_label": "Neutral"}, {"ticker": "CEMI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000695", "ticker_sentiment_label": "Neutral"}, {"ticker": "FIZZ", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.004299", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002684", "ticker_sentiment_label": "Neutral"}, {"ticker": "MLKN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000103", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.015132", "ticker_sentiment_label": "Neutral"}, {"ticker": "AKU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.183661", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "PLSE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002302", "ticker_sentiment_label": "Neutral"}, {"ticker": "SPRB", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003124", "ticker_sentiment_label": "Neutral"}, {"ticker": "TUYA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.200057", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "DAO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002889", "ticker_sentiment_label": "Neutral"}, {"ticker": "ZME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00376", "ticker_sentiment_label": "Neutral"}, {"ticker": "ALPP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024477", "ticker_sentiment_label": "Neutral"}, {"ticker": "GOCO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003664", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005525", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADPT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.007321", "ticker_sentiment_label": "Neutral"}, {"ticker": "NEO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.010813", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLCE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.017888", "ticker_sentiment_label": "Neutral"}, {"ticker": "RCKT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00375", "ticker_sentiment_label": "Neutral"}, {"ticker": "RERE", "relevance_score": "0.003772", "ticker_sentiment_score": "0.004203", "ticker_sentiment_label": "Neutral"}, {"ticker": "VINC", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002099", "ticker_sentiment_label": "Neutral"}, {"ticker": "BNR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000192", "ticker_sentiment_label": "Neutral"}, {"ticker": "VEEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001905", "ticker_sentiment_label": "Neutral"}, {"ticker": "LU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012338", "ticker_sentiment_label": "Neutral"}, {"ticker": "RNG", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.031217", "ticker_sentiment_label": "Neutral"}, {"ticker": "LW", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002687", "ticker_sentiment_label": "Neutral"}, {"ticker": "LX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00118", "ticker_sentiment_label": "Neutral"}, {"ticker": "NOAH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.024247", "ticker_sentiment_label": "Neutral"}, {"ticker": "QTRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00092", "ticker_sentiment_label": "Neutral"}, {"ticker": "APYX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002876", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVDX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008111", "ticker_sentiment_label": "Neutral"}, {"ticker": "MF", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.331932", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "RBLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.226863", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "YUMC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011795", "ticker_sentiment_label": "Neutral"}, {"ticker": "DBTX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010036", "ticker_sentiment_label": "Neutral"}, {"ticker": "AMK", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001564", "ticker_sentiment_label": "Neutral"}, {"ticker": "BLND", "relevance_score": "0.003772", "ticker_sentiment_score": "0.013143", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSHA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00082", "ticker_sentiment_label": "Neutral"}, {"ticker": "LGC-U", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002724", "ticker_sentiment_label": "Neutral"}, {"ticker": "SUMO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001394", "ticker_sentiment_label": "Neutral"}, {"ticker": "OSUR", "relevance_score": "0.003772", "ticker_sentiment_score": "0.028282", "ticker_sentiment_label": "Neutral"}, {"ticker": "ADSK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.006709", "ticker_sentiment_label": "Neutral"}, {"ticker": "DADA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001804", "ticker_sentiment_label": "Neutral"}, {"ticker": "SNOW", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002978", "ticker_sentiment_label": "Neutral"}, {"ticker": "GNSS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.041602", "ticker_sentiment_label": "Neutral"}, {"ticker": "TAST", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.026571", "ticker_sentiment_label": "Neutral"}, {"ticker": "PEGA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.013487", "ticker_sentiment_label": "Neutral"}, {"ticker": "FMTX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00355", "ticker_sentiment_label": "Neutral"}, {"ticker": "MX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001261", "ticker_sentiment_label": "Neutral"}, {"ticker": "LAKE", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005316", "ticker_sentiment_label": "Neutral"}, {"ticker": "AUDC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.008951", "ticker_sentiment_label": "Neutral"}, {"ticker": "RSLS", "relevance_score": "0.007545", "ticker_sentiment_score": "0.016914", "ticker_sentiment_label": "Neutral"}, {"ticker": "TSP", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000325", "ticker_sentiment_label": "Neutral"}, {"ticker": "FUTU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001885", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDLX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005903", "ticker_sentiment_label": "Neutral"}, {"ticker": "DCT", "relevance_score": "0.003772", "ticker_sentiment_score": "0.03092", "ticker_sentiment_label": "Neutral"}, {"ticker": "TLYS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001614", "ticker_sentiment_label": "Neutral"}, {"ticker": "PXLW", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003553", "ticker_sentiment_label": "Neutral"}, {"ticker": "ARNC", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005316", "ticker_sentiment_label": "Neutral"}, {"ticker": "CPTN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002669", "ticker_sentiment_label": "Neutral"}, {"ticker": "ELEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.011302", "ticker_sentiment_label": "Neutral"}, {"ticker": "HYFM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.011591", "ticker_sentiment_label": "Neutral"}, {"ticker": "XBIT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000744", "ticker_sentiment_label": "Neutral"}, {"ticker": "LTH", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001489", "ticker_sentiment_label": "Neutral"}, {"ticker": "GDRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.024689", "ticker_sentiment_label": "Neutral"}, {"ticker": "OPRX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.033841", "ticker_sentiment_label": "Neutral"}, {"ticker": "CTMX", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.018437", "ticker_sentiment_label": "Neutral"}, {"ticker": "CRIS", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.025468", "ticker_sentiment_label": "Neutral"}, {"ticker": "FHI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00941", "ticker_sentiment_label": "Neutral"}, {"ticker": "STNEV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001007", "ticker_sentiment_label": "Neutral"}, {"ticker": "WIMI", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.160316", "ticker_sentiment_label": "Somewhat-Bearish"}, {"ticker": "COCO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.000798", "ticker_sentiment_label": "Neutral"}, {"ticker": "NU", "relevance_score": "0.003772", "ticker_sentiment_score": "0.002419", "ticker_sentiment_label": "Neutral"}, {"ticker": "CDNA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.012574", "ticker_sentiment_label": "Neutral"}, {"ticker": "DDL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003266", "ticker_sentiment_label": "Neutral"}, {"ticker": "ANGH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.03283", "ticker_sentiment_label": "Neutral"}, {"ticker": "PLXP", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003613", "ticker_sentiment_label": "Neutral"}, {"ticker": "MNDY", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000582", "ticker_sentiment_label": "Neutral"}, {"ticker": "GAME", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.005335", "ticker_sentiment_label": "Neutral"}, {"ticker": "UFI", "relevance_score": "0.003772", "ticker_sentiment_score": "0.00244", "ticker_sentiment_label": "Neutral"}, {"ticker": "PRTK", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003877", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIPS", "relevance_score": "0.003772", "ticker_sentiment_score": "0.003349", "ticker_sentiment_label": "Neutral"}, {"ticker": "QFIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010737", "ticker_sentiment_label": "Neutral"}, {"ticker": "KBAL", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.007097", "ticker_sentiment_label": "Neutral"}, {"ticker": "AVYA", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.00594", "ticker_sentiment_label": "Neutral"}, {"ticker": "RPHM", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.002952", "ticker_sentiment_label": "Neutral"}, {"ticker": "APLT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.010934", "ticker_sentiment_label": "Neutral"}, {"ticker": "FINV", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001903", "ticker_sentiment_label": "Neutral"}, {"ticker": "VIOT", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000215", "ticker_sentiment_label": "Neutral"}, {"ticker": "PD", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000522", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIO", "relevance_score": "0.003772", "ticker_sentiment_score": "0.001095", "ticker_sentiment_label": "Neutral"}, {"ticker": "ACRX", "relevance_score": "0.003772", "ticker_sentiment_score": "0.031327", "ticker_sentiment_label": "Neutral"}, {"ticker": "IPA", "relevance_score": "0.003772", "ticker_sentiment_score": "0.005079", "ticker_sentiment_label": "Neutral"}, {"ticker": "NIU", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.001893", "ticker_sentiment_label": "Neutral"}, {"ticker": "WTRH", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.003442", "ticker_sentiment_label": "Neutral"}, {"ticker": "SLNO", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.01092", "ticker_sentiment_label": "Neutral"}, {"ticker": "HAIN", "relevance_score": "0.003772", "ticker_sentiment_score": "-0.000917", "ticker_sentiment_label": "Neutral"}]}]}